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The estimation of vitamin C 
The following abbreviations have been used throughout 
this thesis :- 
AA - L- ascorbic acid 
DHA = dehydro -L- ascorbic acid 
DKG = 2 :3 -diketo -L- gulonic acid 




The earliest methods for the estimation of vitamin C were 
biological and depended on either the prevention or curing of 
scorbutic symptoms in guinea pigs or on the rate of growth of 
young scorbutic animals. Tilimans in 1927 observed that 
fresh lemon juice strongly reduced the dye 2:6-dichlorophenol- 
indophenol. With his associates he later established that 
this reducing power of certain food- stuffs was related to their 
anti- scorbutic potency. At about the same time AA was 
isolated in the crystalline state and since then more precise 
chemical methods for its estimation have been devised to replace 
the tedious biological ones. The biological methods continued 
to be used for some time as a check on the new chemical methods. 
The structure and inter -relations of the compounds of 
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Because of the configuration at carbon atoms 2 and 3 AA 
can be oxidised to DHA and it is a strongly reducing substance. 
This property has formed the basis of many methods for its 
estimation. Since the oxidation is readily reversible, 
techniques which use the reduction of DHA have also been 
developed. The two keto groups formed by the oxidation of AA 
to DHA or DEG may be coupled with 2 :4- dinitrophenyihydrazine to 
form a bis- 2 :4- dinitrophenyihydrazone.. This latter property 
provides the principle underlying another group of methods used 
for the estimation of AA. 
Substances such as indophenol and methylene blue have been 
used to measure the reducing property of AA; the most 
satisfactory of the oxidation- reduction methods are those based 
use 2 :6- dichlorophenol indophenol (indophenol). In 
acid medium indophenol is pink and on reduction it fades to 
the colourless leuco form. The first methods based on this 
reaction were visual titration procedures and titration into 
a known amount of indophenol is still used for the estimation 
of AA in urine. A necessary assumption when using these 
methods is that AA is the major indophenol reducing material 
present. Many substances however, are known to interfere 
with the indophenol reaction and several procedures have been 
devised in attempts to increase the specificity of the 
method. 
Spectrophotometry has been a useful tool in increasing 
the specificity and accuracy of the indophenol methods. 
A quantity of the solution containing AA which is sufficient 
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to partially decolourise the indophenol is used. The decrease 
in colour gives an estimate of the amount of AA present. Three 
advantages of this procedure over visual titration procedures 
are (a) the elimination of inaccuracies due to the difficulties 
in judging the titration end- point, (b) the preparation of a 
blank sample by complete decolourisation of the original solution,, 
so correcting any turbidity or colour in the original solution and 
(c) the possibility of detecting the presence of slowly reacting 
interfering substances. Some of the more notable modifications 
of this method have been suggested by Evelyn, Malloy & Rosen 
(1938), Mindlin & Butler (1937 -38), Loeffler & Ponting (1942), 
Hochberg, Melnick & Oser (1943) and Stewart, Horn & Robson (1953). 
That some vitamin C may exist as DHA in tissues has been the 
subject of investigation since 1932. Application of the indophenol 
technique to tissue extracts after treatment with a reducing agent, 
usually H2S, has been used as a measure of the total vitamin C 
content (AA & DHA). The kinetics of the reduction of DHA to 
AA by H2S have been thoroughly investigated by Levenson, Rosen & 
Hitchings (1951) who showed that the rate of reduction was related 
to the pH of the solution and that reduction was complete only 
over the pH range 1.2 to 4.7. Although the excess of H2S can be 
removed from metaphosoric/acid solutions by N2, many workers 
(Johnson, 1933; Mack & Tressler, 1937; King, 1936; ±essey, 1938a) 
have noted that even after prolonged treatment with N2, traces of 
H2S may still be present in tissue extracts. This fact casts 
serious doubt on the validity of the H2S method since H2S itself 
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reducesindophenol and furthermore it may reduce or combine with 
other compounds present in tissues and these materials may later 
react with the dye. Lugg (1942), Smythe & King (1942) and 
Hochberg et ai. (1943) have shown that this occurs with solutions 
of aldehydes, ketones and quinones and the presence of increased 
amounts of interfering substances has been reported after H2S 
treatment of whole blood filtrates (Butler & Cushman, 1940) and 
of urine (Scarborough & Stewart, 1937). Kellie & Zilva (1936) 
on the basis of ultraviolet absorption spectra analyses suggested 
that this increase was not due to the formation of AA from DHA 
in trichloroacetic acid filtrates of guinea pig plasma treated 
with H2S. 
Certain micro- organisms reduce DHA. Mapson & Ingram (1951) 
have used the ability of Escherichia coli to convert DHA to AA as 
the basis of a method to estimate DHA. After reduction, the total 
indophenol reducing capacity is measured. Such a procedure, 
however, requires careful manipulation of the pH of the extract and 
of the temperature of incubation for the method to be quantitative. 
The method has not found wide use. 
Two methods have been proposed in which a serious attempt has 
been made to remove some of the substances which interfere with the 
indophenol reaction. In 1934 Emmerie & Van Eekelen suggested the 
removal of thiol compounds in tissue extracts by precipitation with 
mercuric acetate. Excess mercuric acetate was removed by treatment 
with H2S. Since Hg ++ tends to oxidise AA to DHA, the H2S ensured 
the reduction of DHA to AA. The method has not been widely used 
because of the laborious H2S procedure and the uncertainties 
about its complete removal from the tissue extracts. The 
second method was designed to permit the determination of AA in 
the presence of sulphites, sulphides, thiol compounds and 
reductones. The method was proposed by Lugg (1942) who discovered 
that HCHO will condense with these materials and with AA to an 
extent depending on the pH. Condensation with HCHO destroys 
the indoahenol reducing capacity. At pH 1.5 HCHO condenses 
very rapidly with sulphite, sulphide and thiol compounds but only 
very slowly with AA. AA is however unstable with HCHO at pH 3.5. 
This principle has been extended by Snow & Zilva (1943, 1944) and 
by Mapson (1943). The latter has used it to determine AA in 
urine and in certain treated foods in which reductones occur. 
He used pH 0.6 for condensation of the S- compounds and although 
he did not find any pH at which HCHO condenses with AA and not 
with the reductones, at pH 2 AA condensed fairly rapidly and the 
reductones slowly and at a linear rate, By measuring the 
reducing capacity at pH 2 at intervals after the addition of HCHO 
it was possible to construct a reductone reducing curve which on 
extrapolation to zero gave the indophenol reducing capacity of 
the reductones. The difference between this value and the value 
at pH 0.6 was considered to give the AA value. More recently 
Mapson (1953) has simplified the procedure for determining AA in 
urine. The difference in indophenol reducing capacity after 
condensation at pH 0.6 and 3.5 is taken as a measure of the AA. 
Unfortunately these methods are extremely laborious and the 
recovery of AA added to tissue extracts is often low. Since the 
calculation is based on a difference, it is most unsuitable for 
estimating low concentrations of AA. 
Methods based on the oxidation of AA to DHA and DKG and the 
formation of the ozazone of DKG with dinitrophenyihydrazine have 
been developed by Roe and his co -workers. Such methods possess 
a high degree of specificity and since they involve mild oxidation 
with charcoal the uncertainties associated with the instability of 
AA and indophenol are overcome, as is the risk of including 
interfering materials. The procedure devised by Roe & Kuether 
(1943) can be used satisfactorily with most biological materials. 
Roe, Mills, Oesterling & Damron (1948) modified the method so that 
AA, DHA and DKG could be estimated separately. A micro- method 
which requires only 0.01 ml. of blood has been developed by Bessey, 
Lowry & Brock (1947), and Lowry, Lopez & Bessey (1945). In all 
these methods the coupling reaction is carried out in a mildly 
reducing medium obtained by the use of thiourea or stannous chloride 
which is claimed to reduce interference from non -AA chromogens. 
The ozazone in concentrated H2SO4forms a soluble, stable, red 
compound which has a maximum absorption at 518". 
Schaffert & Kingsley (1955) suggested on the basis of work by 
Penney & Zilva (1943a,b; 1945) that the incubation time can be 
reduced to 5 min. if the temperature is raised to 100 °C. 
Separate determination of AA is achieved by omitting the charcoal 
oxidation stage. Geschwind, Williams & Li (1951) also modified 
the procedure for the estimation of total AA in adrenals by increasing 
the temperature of the coupling reaction. Bolin & Book (1947) 
suggested a modification so that the method can be used with 
metaphosphoric acid extracts of tissues instead of 
trichloroacetic acid extracts. This allows both indophenol and 
phenylhydrazine procedures to be carried out on the same extract. 
In place of charcoal, to which some AA may be adsorbed, indophenol 
is used as the oxidising agent. 
The choice of a method to be used for the estimation of AA in 
biological tissues depends on the kind of information and the 
degree of accuracy desired. If only the total AA is needed the 
Roe & Kuether method is probably the most accurate. The selection 
of a method suitable for the precise estimation of AA is made 
difficult by the number of compounds which decolourise the dye and 
which may be present in tissue extracts, e.g., H2S, thiosulphate, 
sulphite, thiol compounds, phenols and reductones. Harris & Mapson 
(1947) using a 'bontinuous flow" method found that most of these 
substances react more slowly than does AA at pH 3.5 and 2000. 
Of the substances examined only hydroxytetronic acid reacted in 
the same manner as did AA. Several workers have shown that the 
pH at which the reaction proceeds is critical, and it is generally 
agreed that pH 3.5 to 4.5 is most satisfactory. The buffers, 
sodium acetate (Mindlin & Butler, 1937 -38) or sodium citrate 
(Bessey, 1938a,) have been used to ensure this pH range, outside 
of which interfering materials react to a greater extent. Harris 
& Mapson (1947) showed that thiosulphate, dihydroxymalic acid and 
Fes'. react slowly at pH 3.5 and much more rapidly at pH 1.4. 
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On the other hand GSH, cysteine and sulphite react faster at the 
higher pH. The presence of many of these interfering materials 
has been demonstrated in biological tissues e.g. kidney (Hopkins 
& Slater, 1935); brain (Young & Mitolo, 1934); whole blood 
(Butler & Cushman, 1940); urine (Evelyn et al., 1938 and 
Scarborough & Stewart, 1937); semen (Mann & Leone, 1953). On 
the other hand Butler & Cushman (1940) reported that human plasma 
does not contain substances which react slowly with indophenol. 
Investigations on the state in which vitamin C exists in the 
tissues and particularly in blood and its components have been 
greatly hampered by the lack of a method specific for DHA and by 
the unreliability of the indophenol methods. Most early workers 
considered that plasma vitamin C existed in the reduced state 
(Borsook, Davenport, Jeffreys & Warren, 1937; Kellie & Zilva, 
1936; Farmer & Abt, 1936). In contrast, Van Eekelen, Emmerie, 
Josephy & Wolff (1933), Plaut & Bülow (1935), and Fujita & 
Ebihara (1937) reported that it was present entirely as DHA. 
Van Eekelen later considered that it was indeed in the reduced 
state. More recently it has been shown that not more than 0.25 
100 ml., and more usually between 0.05 and 0.15 mg/100 ml. of 
DHA is present in plasma (Daubenmerkle, 1949; Lloyd, Sinclair 
& Webster, 1945; Chen & Schuck, 1950; Davey, Wu & Storvick 
1952; Banerjee & Belavady, 1953; Stewart, Horn & Robson, 1953; 
Linkswiler, 1954). No comparable analyses have been reported 
for erythrocytes probably because of the lack of specificity of 
the indophenol methods. Furthermore, acid precipitation of 
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oxy- haemoglobin is known to cause oxidation of AA (Lemberg, 1942). 
Total AA values of erythrocytes closely follow the plasma values 
(Lubschez, 1945). 
The amount of BHA reported in plasma is very small and 
therefore the accuracy of the methods used for its estimation 
need to be examined critically. Furthermore since its 
estimation depends on a determination by difference the accuracy 
decreases alarmingly when the total AA concentration is low. 
The purpose of the experiments reported in this section 
was the critical examination of the indophenol reaction and 
its suitability for determining the AA content of plasma, 
erythrocytes, urine, liver and kidneys. In an attempt to 
improve the specificity of the reaction for AA the use of a well 
known -SH inhibitor, p- chloromercuribenzoic acid (CMB) has been 
used. A method by which this material can be applied to 
extracts of plasma, erythrocytes, urine and tissues is described. 
A preliminary account of the CMB technique has been published 
(Owen, Iggo & Horn 1954), and a full account of the method and 
its applications has been accepted for publication in the 
Biochemical Journal (Owen & Iggo, 1955, in the press). 
A comparison of the indophenol and dinitrophenylhydrazine 
procedures applied to extracts of plasma, erythrocytes and 
urine is reported. 
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MATERIALS AND METHODS 
General Reagents : The general reagents used for the 
estimation of vitamin C are listed below. Other reagents used 
in a few experiments were of AR quality and are mentioned in the 
appropriate places. 
Metaphosphoric acid. (BDH) 20% (w /v) A stock solution was 
made up at intervals of not longer than four days and stored in 
a refrigerator. This solution was diluted as required. 
2 :6- dichiorophenol indophenol. Preparation A, sodium salt 
(L.Light & Co.) A solution containing 100 mg. /100 ml. was 
made up at weekly intervals and diluted as required. 
Preparation B, Tablets (BDH) equivalent to approximately 1 mg. AA. 
A solution containing 2 tablets /100 ml. was made up. daily and 
filtered. No difference was found between these two preparations. 
L- ascorbic acid (Roche). 
L- dehydroascorbic acid. Prepared by oxidation of AA by quinone 
according to the method of Patterson (1950). 
Sodium citrate (AR). 30% (w /v). This solution was diluted as 
required. 
Sodium acetate buffer. (pH 4.0) . 1.8 vol. of 0.2N sodium acetate 
solution was added to 8.2 vol. of 0.2N acetic acid. 
Formaldehyde (AR). A 40% (w /v) solution. 
p- chlormercuribenzoic acid. (CAB). Prepared according to the 
method of Whitmore & Woodward (1946) . 200 mg. /100 ml. in 0.05N 
NaOH. 
Trichloroacetic acid (AR) 6% (w /v) 
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Activated charcoal (BDH). Acid washed. 
Thiourea (AR) . 10g. dissolved in 100 ml. 50% (v /v) alcohol. 
2 :4- dinitrophen;,lhydrazine (AR) . 2g. in 100 ml. 9N H2SO4. 
This solution was filtered through Whatman No.42 filter paper 
and kept at 5 °C. 
Sulphuric acid (AR). 85% (v /v). Prepared by diluting 900 ml. 
conc. H2SO4 with 100 ml. water. 
Preparation of biological extracts. 
Plasma: For the indophenol method, protein -free filtrates of 
human plasma (oxalated or heparinised) were prepared by adding 
2 vol. of plasma to three vol. of 3% (w /v) metaphosphoric acid. 
After 15 min. a clear solution was obtained by filtration through 
Whatman No 42 paper. 
For total ascorbic acid 1 vol. of plasma was added to 3 vol. 
of 6% (w /v) trichloroacetic acid. 
Er throçytes. Whole blood (oxalated or heparinised) was 
centrifuged and the white cell layer removed as completely as 
possible. The erythrocytes were resuspended in the plasma and 
transferred to a tonometer. A steady stream of CO generated from 
sodium formate (AR) and conc. H2SO4 was passed into the tonometer 
for 15 to 20 min. Rotation of the tonometer during this time 
ensured complete saturation of the blood with CO. After 
centrifugation 2 vol. of erythrocytes were added to 3 vol. of 
6% (w /v) metaphosphoric acid for the indophenol method. For 
total AA estimations 1 ml. of CO saturated erythrocytes was added 
to 3 vol. of 6% (w /v) trichloroacetic acid. 
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Urine. Freshly voided human urine, after filtration, was diluted 
to give an AA concentration of approximately 1 mg. /100 ml. 
To 3 vol. of 3% (w /v) metaphosphoric acid were added .27 vol. of 
diluted urine. 
For total AA determination 1 vol. diluted urine was added to 
3 vol. of 4% (w /v) trichloroacetic acid. 
Preparation of AA standards. 
Calibration curves for all experiments were prepared with 
standard solutions of AA made by diluting, immediately after 
preparation, a 100 mg. /100 ml. solution of AA to give final 
concentrations of 0.25, 0.5, 1.0, 1.5 and 2.0 mg. AA/100 ml. 
For the indophenol estimations 2 vol. of each of these solutions 
was immediately added to 3 vol. of 3% (w /v) metaphosphoric acid. 
For the total AA estimations 1 vol. of the same standard solutions 
was added to 3 vol. of 6% (w /v) trichloroacetic acid. 
Measurement of indophenol reducing activity. 
The method employed was basically that used by Evelyn, Malloy 
& Rosen (1938) and is termed the "buffered indophenol" method. 
Into a 10 ml. cuvette was pipetted 2 mi. of the test solution, 
0.5 ml. of sodium citrate (concentration depending on the final 
pH required) and 1.0 ml. indophenol. After rapid mixing the 
optical density of the solution was measured at 520 in? in a Unicam 
S.P.600 spectrophotometer. Any slight turbidity or colour in the 
test solution was allowed for by measuring the optical density after 
decolourising the remaining indophenol with a small amount of AA. 
Indophenol reducing activity measured by the "unbuffered indophenol" 
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method was obtained by using the same method but without the 
sodium citrate. The calibration curves for both methods were 
obtained by treating the metaphosphoric acid solutions of the 
standards in precisely the same manner as the test solutions. 
H2S procedure for the measurement of AA DHA. 
Pure H2S, generated by warming Sb2S5 (AR tartar emetic) and 
cone. HC1 to 68 °C, was bubbled for 10 min. through metaphosphoric 
acid solutions of AA, DHA and filtrates,of plasma and erythrocytes 
of pH 1.5 or adjusted to pH 3.5 with sodium citrate. The 
solutions were allowed to remain saturated with H2S for a further 
30 min. Excess H2S was then removed by blowing N2 saturated 
with water vapour through the solutions for at least 3 hr. 
The temperature of the test solutions was held at 37 °C. Both 
lead acetate and nitroprusside were used to test for traces of 
H2S. AA was then estimated by the 'buffered" and "unbuffered" 
indophenol methods. 
Formaldehyde procedure for the measurement of 
This determination was based on a method suggested by Mapson 
(1953) . Condensation with HCHO at pH 0.6 was carried out by 
allowing 5 mi. of a metaphosphoric acid extract of urine to 
react with 1 ml. of 2% (WV) H2SO4 and 1.5 ml. of 40% HCHO 
(adjusted to pH 0.6 with conc. H2SO4). Aliquots of 2 ml., 
removed at 12 min, 24 min, and 36 min, were added to tubes 
containing 0.3 ml. of 30% sodium citrate and 1 ml. of indophenol. 
After rapid mixing the material was transferred to spectrophoto- 
metric cuvettes and the optical density measured exactly 30 sec. 
after the addition to the indophenol. For condensation at 
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pH 3.5, 1 ml. of 15% (w /v) sodium citrate and 1.5 ml. of HCHO 
previously adjusted to pH 3.5 were added to 5 ml. of urine extract. 
The mixture was again allowed to react for 12, 24, and 36 min. 
The indophenol reducing activity was measured by taking 2 ml. of 
the reaction mixture, 0.3 ml. of water and 1 ml. indophenol. 
Blank values obtained by decolourising the remaining indophenol 
with a slight excess of AA were substracted to correct for the 
natural colour of the urine. Graphical extrapolation to zero 
time of the values obtained at 12, 24 and 36 min. after adding the 
ECHO were related to values obtained for standard solutions of AA 
treated in a similar manner. The difference between the values 
obtained by condensation with HCHO at pH 0.6 and 3.5 represents 
the AA content of the urine. 
Procedure using p- chloromercuribenzoic acid. 
To 3 vol. of a metaphosphoric acid extract of plasma, 
erythrocytes or urine, 1 vol. of OMB was added. Because of the 
low solubility of the reagent at this pH (about 1.5) most of 
excess reagent precipitated, together with any insoluble complex 
formed by the reagent with materials in the test solution. 
After standing 5 min. the precipitate was removed by centrifugation 
and the indophenol reducing activity of the clear supernatant was 
determined by the "buffered indophenol" method. 
Procedures for the estimation of total AA. 
Methods using charcoal as the oxidising agent. 
The method of Roe & Kuether (1943) originally described for 
blood was used for estimating the total AA of plasma, erythrocytes 
and urine. A trichioroacetic acid extract of the test material 
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was shaken with 0.45 g. of acid- washed activated charcoal on a 
mechanical shaker for 5 min. and filtered through a No.42 filter 
paper. A drop of thiourea was added to 2 ml. of the filtrate, 
then 0.5 ml. phenylhydrazine reagent was added and mixed. The 
mixture was then incubated for 3 hr. at 37 °C. The mixture was 
ice cooled and 2,5 ml. of 85% H2SO4 was added slowly with 
thorough mixing. The optical density of the red- brown colour 
which developed during the next 30 min. was read at 540m». in the 
spectrophotometer. The Geschwind modification of this method, 
in which the incubation time is reduced to 45 min. at a temperature 
of 61 °C has also been used. 
Blank determinations were carried out in two ways, (a) The 
charcoal treated filtrates of AA standards or the test material 
without dinitrophenylhydrazine were incubated, and cooled. The 
dinitrophenylhydrazine was then added and immediately after it 
H2SO4. (b) A 4.5% (w /v) solution of trichloroacetic acid 
(diluted from 6 %) was treated in exactly the same way as the 
test solutions. 
Procedure using; l indoheno as the oxidising agent. 
The method described by Bolin & Book (1947) was used on 
metaphosphoric acid extracts of plasma and urine. To 2 vol. of 
the test extract was added 1 drop of indophenol of such concen- 
tration that a faint pink colour persisted after shaking. An 
equal volume of a solution containing 4% (w /v) metaphosphoric 
acid and 2% (w /v) thiourea was added and then 1 vol. of 
dinitrophenylhydrazine reagent. Incubation, colour development 
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with 5 vol. of 85% H2SO4 and measurement of the optical density 
was as for the Roe & Kuether method. A slight modification of 
this method was also used. It was found that 1 drop of thiourea 
was sufficient to decolourise the pink colour of the indophenol 




The stability of Indophenol. 
The fading of indophenol, in the absence of substances 
known to reduce it, has been examined by following the decrease 
in optical density at minute intervals of a solution containing 
2% (w /v) metaphosphoric acid and 1 ml. of indophenol. 0.5 ml. 
of sodium citrate of varying concentration or of water or of 2% 
metaphosphoric acid were added to adjust the pH of the final 
mixture to 4.2, 3.5, 2.6, 2.1, and 1.9. The rate of fading is 
shown in Fig.l. At pH 4.2 there was no fading and the dye in 
fact remained stable for at least 30 min. As the pH was 
reduced the rate of fading was progressively increased, When 
sodium acetate buffer was used in place of sodium citrate, indo- 
phenol again remained stable at pH 4.0. Mindlin & Butler 
(1937-38) also observed fading of indophenol at low pH using 
phosphate buffers of pH 1.9 and 2.0. The rate of fading is 
therefore largely determined by the pH and at a pH below 2.0 a 
small change in pH can cause a considerable change in the rate of 
fading. From these results a pH of 4.0 must be regarded as the 
most satisfactory one.for measuring indophenol reducing activity 
since spontaneous fading of the dye is negligible at this pH. 
Fading of indophenol in the presence of ascorbic acid. 
Partial stabilisation of indophenol can be achieved by the 
addition of AA. This effect was examined by measuring the 
optical density of indophenol added to 2% (w /v) metaphosphoric 














Fig.l. The effect of pH on the 
stability of indophenol. pH:- A, 
4.2; 
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Fig.2. The effect of AA on the stability of indophenol at pH 1.5. 
Test solutions of HP03 containing A9. (mg. /100m1.) A, No AA; 
B, 0.25; C, 0.5; D, 1.0. Broken lines show that no fading of 
indophenol occurred in these solutions during 4 min. at pH 4.0 
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Fig. 2 shows the rate of fading in 4 min. of these solutions 
(pH 1.5) and of the same solutions adjusted to pH 4.0 with sodium 
citrate. With increasing concentrations of AA the rate of fading 
of the dye is decreased, while at pH 4.0 no fading occurred in any 
of the solutions. 
Since the rate of fading varies according to the concentration 
of AA initially present it is important that the reaction mixture 
is buffered to about pH 4.0 when concentrations of less than 1 mg/.100m1 
of AA are being measured. Under ordinary conditions the concentrat- 
ion of AA in blood i.s generally less than 1 mg. /100m1. The 
increase in reducing activity of indophenol in the presence of AA 
expressed ad "apparent ascorbic acid" is shown in Fig. 3. Sixty 
seconds after the addition of indophenol the reducing activity of 
the reaction mixture containing 0.25 mg. /100m1. AA had increased 
by the equivalent of 0.1 mg. /100m1. AA. The base line was 
obtained with all the solutions when the pH was increased to 4.0, 
showing that the reduction of indophenol by AA was complete in 
30 sec. and that no further reduction occurred. 
In view of this finding it is not surprising that AA 
calibration curves prepared at low pH e.g. by the "unbuffered 
indophenol" method deviate from linearity below 0.5 mg. /100m1. 
(Fig.4) In contrast, calibration curves prepared by the 
"buffered indophenol" method i.e. at pH 4.0, are strictly linear. 
Fading of indophenol by various sulphur -containing compounds. 
Thiols and some other compounds containing sulphur can 
reduce indophenol. The rate of fading of indophenol in 2% 
^ 1.0 
r--i 
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TIME (min.) 
Fig.3. The apparent increase in ascorbic acid content of standard 
solutions of AA in HP03 at pH 1.5. Concentration of AA (mg. /100m1.) 
A, No AA; B, 0.25; C, 0.5; D, 1.0: The base line shows no increase 
in AA in all the solutions at pH 4.0. 
E 
0.5 1.0 1.5 2.0 
ASCORBIC ACID (mR./ 100m1.) 
Fig.4. Calibration curves for the estimation of AA. A, by the 
'unbuffered indophenol' method; B, by the 'buffered indophenol' 

























































































































































































































































































































































































































































































































































































































































metaphosphoric acid solutions of the following substances was 
4 
measured at pH 4.6; methionine 5 x 10 M, glutathione 5 x 10-4M, 
cysteine 5 x 10-4M, thioglycolic acid 2 x 10 -4M, H2S 5 x 10-4M, 
thiosulphate 0 l60 x 10 -4 thiourea 15 x 10 -4M, and sulphite 
2.5 x 10.4. Indophenol at a concentration of 4mg./100m1. was 
used and the optical density of the solution was measured at 
intervals for five minutes after adding the dye (Fig.5). 
Thiosulphate and thiourea reacted rapidly with indophenol; by 
60 sec. most of the fading had occurred and the dye was stable 
after 2 min. By contrast a solution containing 1.0 x 10 -4M 
AA was stable 30 sec. after adding the dye. The other compounds 
reacted more slowly and the fading of indophenol was incomplete at 
5 min. At pH 3.5 (Fig.6) all the solutions except ergothionetine 
and thiourea, which are shown in Fig.7, reacted more slowly with 
indophenol than at pH 4.6. The indophenol reducing activity 
of these solutions, expressed as mg./100m1. 'a.pparent ascorbic acid ", 
is given in Table 1 and it can be seen that the presence of these 
substances could seriously interfere with the estimation of AA 
by the indophenol method. Other groups of substances such as 
reductones, pheonols, dihydroxymalic acid and hydroxytetronic 
acid will also reduce indophenol but were not examined. 
The use of the indophenol method to estimate AA in mammalian tissues. 
Protein precipitation. 
Metaphosphoric acid is the most suitable reagent for precipi- 
tating tissue proteins before applying the indophenol reaction. 
Protein determinations were done on plasma and erythrocyte filtrates 
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Fig. 5. The rates of reaction of S compounds with indophenol at pH 
4.6. A, control; B, methionine, 5 x 10-4M; C, thiourea,15 x 10-4ivÌ; 
D, Na2S203, 0.6 x 10-4M; E, H2S,.5 x 10-4M; F, Na2S03, 2.5 x 10-41Ví; 
G, glutathione, 5 x 10-4M; H, thioglycollic acid, 2 x 10-4M; J, 
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Fig.6. The rates of reaction of S compounds with indophenol at pH 3.5. 
A, control; B, Na2S207, 0.6 x 10 -4M; C, H2S, 5x 10 -4M; D, glutathione, 
5 x 10 -4M; E, thioglycollic acid, 2 x 10 -4ï.; F, cysteine, 5 










Fig.7. The rates of reaction of ergothioneine and thiourea with 
indophenol at pH 4.6 and 3.5. A, ergothioneine (5 x 10 
-4M) 
at pH 
4.6; B, thiourea (15 x 10 -4M) at pH 4.6; C, ergothioneine at pH 3.5; 
D, thiourea at pH 3.5. 








Blank Total AA N.P.N. 





Plasma .A 3 0.13 0.13 0.045 29.5 
6 0.12 0.14 0.049 30.5 
0.16 
10 0.14 0.11 0.050 35.5 
15 0.13 0.13 0.049 43.0 
Plasma B 3 0.09 0.11 0.041 32.0 
6 0.09 0.13 0.049 31.5 
0.10 
10 0.11 0.11 0.047 35.0 
20 0.09 0.14 0.047 54.0 
Cells A 3 insufficient to precipitate the protein 
(no CO) 6 0.16 0.07 0.049 42.5 
0.16 
10 0.16 0.12 0.057 45.0 
15 0.25 0.01 0.059 47.5 
Cells B 10 0.47 0.02 0.057 45.0 




acid. The total N content of plasma filtrates increased as 
the metaphosphoric acid concentration was raised from 3% to 20% 
(Table 2). The filtrates prepared with 3% were quite clear 
but above this concentration they were slightly cloudy; this is 
reflected in the higher blank values. When 3% metaphosphoric 
acid was used to precipitate protein from erythrocytes a brownish 
filtrate containing protein was obtained. A clear filtrate was 
obtained when 6% metaphosphoric acid was used but at higher 
concentrations the precipitation of protein was incomplete. 
In all subsequent experiments 3% and 6% metaphosphoric acid 
was used for the precipitation of protein in plasma and erythro- 
cytes respectively. 
Fading of indophenol_ in protein -free filtrates of plasma. 
Ascorbic acid was added to plasma in amounts sufficient to 
give final concentrations of 0.25, 0.5, 1.0 mg. /100m1. The 
indophenol reducing activity of protein -free filtrates of these 
solutions was measured at intervals for 4 min. (Fig.8). 
Continuous fading of indophenol occurred with all the solutions 
but it was less rapid at the higher concentrations of AA. The 
AA solutions added were the same as those used in Fig.2 but the 
rate of fading was less rapid, probably because the pH of the 
final solution is slightly higher when the same solution of 
metaphosphoric acid is added to pure solutions of AA and to 
plasma solutions of AA. When the pH was raised to 4 by the 
addition of sodium citrate no fading of the solutions occurred 
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Fig.8. The effect of AA on the stability of indophenol with plasma 
filtrates at pH 1.5. Concentration of AA (mg. /100m1.) :- A, no 
AA; B, 0.25; C, 0.5; D, 1.0. Broken lines show that no fading of 
















Fig.9. The apparent increase in AA content of standard solutions 
of AA added to plasma filtrates of pH 1.5. Concentration of AA 
(mg. /100m1.):- A, no AA; B, 0.25; C, 0.5; D, 1.0. The base line 
shows no increase in AA in all the filtrates at pH 4.0. 
21. 
If the same pH could be reached in filtrates of plasma and 
standard solutions of AA an accurate estimate of the plasma AA 
could be obtained using the indophenol method. However some 
metaphosphoric acid is always used in the precipitation of the 
plasma proteins so that the final pH is never the same. Since 
the rate of fading is so dependent on pH, particularly below pH 2, 
the rate of fading of indophenol will always be faster in the 
standard solutions than in the plasma filtrates. .Because of 
this the AA content will be underestimated. For this reason 
an accurate measure of plasma AA will be obtained only when the 
pH of the reaction mixture is about pH 4, at which pH the spontan- 
eous fading of both standard solutions and plasma filtrates is 
arrested. 
Fading of indophenol in protein -free filtrates of erythrocytes. 
Fading of indophenol in CO- saturated erythrocyte filtrates 
is much greater than in filtrates of plasma. The apparent 
increase in AA at high pH is shown in Fig.10 for three different 
cell filtrates. At no pH is fading completely arrested and in 
fact it is greater at the higher pH values. Evidence will be 
presented later to show that the presence of interfering substances 
is chiefly responsible for this increase. When the pH was raised 
from 2.4 to 5.1 there was a 10 -fold increase in the apparent AA 
content of filtrate A and a 4 -fold increase in filtrate B. 
pecificity of the indo henol method. 
The fading of indophenolin the presence of thiol and other 
S- containing compounds has already been discussed. These 
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Fig.lO. The effect of pH on the apparent AA content of 3 filtrates 
of erythrocytes. 
TABLE 3. The effect of CIVIB on the recovery of AA 
Original AA 
Material content AA added AA found Recovery 
(mg /100m1) (mg /100m1) (mg/100ml) ( %) 
Plasma 0.12 1.0 1.16 104 
Erythrocytes 0.18 0.33 0.50 96 
1.0 1.17 99 
Urine 0.98 1.0 2.00 102 
Plasma filtrate 1.06 1.0 2.10 104 
Erythrocyte 
filtrate 
0.74 1.0 1.71 97 
Urine filtrate 1.00 1.0 1.99 99 
Liver filtrate 1.13 1.0 2.18 105 
TABLE 4. The effect of CMB on the apparent AA contant of plasma, 
erythrocytes and urine 
(Results as means and range) 
AA AA 
Material n Without CMB With CMB Difference 
(mg /100m1) (mg /100m1) (mg/100m1) 
Plasma 41 0.56 0.55 0.01 
(0.09 - 1.40) (0.10 - 1.40) (-0.09 -'+0.07) 
Erythrocytes 12 0.47 0.25 0.22 
(0.21 - 1.39) (0.10 - 0.94) ( +0.01 - +0.45) 
Urine 12 0.77 0.65 0.12 
(0.19 - 1.92) (0.02 - 1.79) (0.00 - +0.26) 
22. 
SH- inhibitor, p- chlorolnercuribenzoic acid (CMS), in an attempt to 
increase the specificity of the indophenol reaction was therefore 
investigated. The standard curves obtained by the "buffered 
indophenol" method before ánd after the addition of CMB are shown 
in Fig.11 for solutions containing 0.5, 1.0, 1.5, 2.0 and 3.0 
mg. /100ml. AA. Good recoveries of AA added to plasma, erythrocytes 
(after haemolysis with saponin and ,saturation with CO) and diluted 
urine were obtained with the CM method. AA added to metaphosphoric 
acid filtrates of plasma, erythrocytes, urine and liver was also 
satisfactorily recovered when estimated by the CMB method (Table 3). 
These results indicate that CMB does not interfere with the reaction 
of indophenol with AA. The effectiveness of CM3 in removing . -con- 
taining compounds from 21 metaphosphoric acid solutions was then 
tested. CMB effectively suppressed the indophenol reducing 
activity at pH 4.5 of all the compounds tested (Table 1). The 
effect of CMB on protein free filtrates of plasma, erythrocytes 
and urine was therefore tested. The 'a.pparent AA content" 
measured by the "buffered indophenol" method with and without the 
addition of CM13 for 41 plasma, 12 erythrocyte and 12 urine filtrates 
are given in Table 4. No difference was observed after the 
addition of C1&ß to plasma filtrates. However the "apparent AA 
content" of the erythrocyte and urine filtrates was reduced by 
50 and 151 respectively. The absence of slowly reacting sub- 
stances from plasma is shown in Fig.12. There was no slow fading 
during 4 min. at pH 4.5 (curve D) and the results with and without 
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Fig. 11. Calibration curves for the estimation of AA. A, by the 
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Fig. 12. The effect of CMB on the indophenol reducing activity of 
filtrates of plasma and erythrocytes at pH 3.5 and 4.0. A, 
erythrocyte filtrate at pH 4.5; B, erythrocyte filtrate at pH 3.5, 
Cl plasma filtrate at pH 3.5; D, plasma filtrate at pH 4.5 and 
with CMB at pH 3.5 and 4.5; E, erythrocyte filtrate with CIM at 
pH 4.5. 
TABT,R 5. The effects of pH and CMB on the indophenol reducing 
activity of erythrocy Les 
Indophenol reducing activity 
Material pH 'buffered method' CMB method Difference 
(mgAA /100m1) (mgAA /100m1) 
Blood A 2.4 0.20 o 
2.7 0.21 0.01 
3.4 0.38 0.18 
4.3 0.98 0.20 0.78 
4.8 1.65 1.45 
5.1 1.98 1.79 
5.3 2.12 1.92 
Blood B 2.4 0.56 0.31 
2.9 0.62 0.37 
3.5 0.92 0.25 0.67 
4.6 1.81 1.56 
5.1 2.17 , 1.92 
Blood C 3.1 1.39 0.34 
3.4 1.44 0.39 
1.05 
3.9 1.55 0.50 
4.7 2.10 1.05 
Blood D 
(no CO) 
2.0 0.29 0.26 
4.5 0.47 0.03 0.44 
4.9 1.34 1.31 
23. 
reacting substances (Curve A & B Fig.12) as is shown by the increase 
in "apparent AA ". This increase is largely due to substances which 
react more rapidly at the 'nigher pH values (Curve A & B). The 
addition of CAB almost completely removes these interfering 
substances since there was no apparent increase in AA when MIN was 
added (Curve E Fig.12). The striking effect which pH has on the 
AA values of erythrocytes is shown in Table 5. This effect of 
pH was absent after the addition of CM3. Above pH 4.5 the 
difference between the two methods was greater than 1 mg. /100m1. 
AA. Substances such as glutathione and cysteine which a re known 
to occur in erythrocytes behave in this manner and may be responsible 
for the increase. When added to plasma they cause slow continuous 
fading of indophenol which is completely arrested by the addition of 
OMB (Fig. 13). 
The effect of adding CAB to 2 diluted urine filtrates is shown 
in Fig.14. Urine contains substances which react slowly with 
indophenol at high pH values (Curve A & D) but their effect is only 
partly removed by treatment with CJíB ( Curves C & E). Some of the 
interfering substances in urine are therefore probably S- containing 
compounds. Urine also contains other compounds, possibly phenols, 
which are not affected by CPtB. When GSH and cysteine were added 
to urine filtrates they caused slow continuous fading of indo- 
phenol (Fig.15). 
In a few experiments it was shown that extracts of rat liver 
and kidney also contain considerable amounts of substances which 
react 
¡slowly 











Fig. 13. The effect of glutathione and cysteine on. the indophenol 
reducing activity of plasma filtrates at pH 4.2. Glutathione 
concentration, 20mg. /100m1; cysteine concentration, l0mg. /100m1. 
A, plasma filtrate; plasma filtrate + glutathione or cysteine + 





Fig.l4. The effect of pH and CMB on the indophenol reducing 
activity of 2 diluted urines. Urine i :- A, pH 4.2; B, pH 3.5; 








Fig.15. The effect of glutathione and cysteine on the indophenol 
reducing activity of diluted urine at pH 4.2. Concentration of 
glutathione, 20mg. /100m1; concentration of cysteine 10mg. /100m1. 
A, diluted urine + CMB; B, diluted urine; C, diluted urine + 
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Fig.16. The effect of CMB on the indophenol reducing activity of 
rat liver and kidney filtrates. A, kidney filtrate; B, liver 
filtrate; C, liver filtrate + CMB; D, kidney filtrate + CMB. 






CMB method Roe method 
(mg /100ml) (mg /100ml) 
0.22 0 0.11 
0.29 0.02 0.11 
0.17 0.07 0.16 
0.16 0.07 0.16 
0.58 0.04 0.47 
TABLE 6. The effect of CMB on the indophenol reducing activity of 
sulphur compounds added to biological materials 
The compounds were added in amounts calculated to give an 
indophenol reducing activity approximately equal to lmg AA /100ml. 
Results 
Material 












1.11 1.12 1.12 1.11 1.12 
1.01 1.01 1.06 1.02 1.04 
1.06 1.12 1.12 1.06 1.04 
Erythrocyte 
filtrates 
0.58 0.60 0.61 0.63 0.58 
0.53 0.58 0.49 0.50 0.54 
0.78 o.77 0.72 0.75 
Diluted urine 0.79 0.77 0.79 0.75 o.77 
1.00 1.00 1.00 1.00 1.08 
0.68 0.66 0.58 0.64 0.64 
Diluted liver 1.13 1.13 1.13 1.13 1.14 
filtrate 
24. 
When glutathione, cysteine, H2S and thiosuiphate, in 
amounts calculated to give a reducing activity equivalent to 
approximately i mg. /100m1. AA, were added to filtrates of plasma, 
erythrocytes, urine and rat liver, their reducing effect was 
completely inhibited by the addition of sufficient CMB. (Table 6). 
Oxidation of ascorbic acid by_ oxyhaemoglobin. 
It is well known that precipitation of erythrocyte protein 
not previously saturated with CO leads to the loss of AA due to 
its oxidation by the haemoglobin released. The usefulness of 
CJEB as a means of removing interfering substances is well 
illustrated by a comparison of AA values of erythrocytes not 
treated with CO measured by the "buffered indophenol" method 
with and without CMB (Table 7). Practically no AA was 
detected in the protein -free filtrates after CMB treatment where- 
as a large amount of "apparent AA" was measured in the absence 
of CMB. Comparison of the values obtained by the CMB method 
and by the Roe method for total AA shows that practically all 
the AA had been oxidised to DHA by the precipitation procedure. 
The values obtained by the "buffered indophenol" method without 
CMB could not represent the true AA content. Oxidation of 
AA also occurs in plasma after slight haemolysis. The AA 
content of 1 plasma measured by the "buffered indophenol" method 
was reduced from 0.88 mg. /100m1. to 0.62 mg. /100m1. after slight 
intentional haemolysis. 
TABLE 8. Comparison of different methods for the determination of 
of total AA in plasma Results as mg/100ml. 














0.09 0.09 0.09 0.07 0.09 
0.13 0.11 0.11 . 0.13 0.10 
0.20 0.25 0.20 0.18 0.20 
0.22 0.21 0.26 0.23 0.24 
0.27 0.23 0.27 0.29 0.27 
0.29 0.24 0.27 0.29 0.28 
0.36 0.35 0.34 0.36 0.40 
0.41 0.50 0.44 0.46 0.46 
0.55 0.46 0.53 0.54 
0.61 0.65 0.62 0.71 0.65 
0.65 0.61 Q.64 0.66 0.66 
0.79 0.85 0.80 0.87 
0.81 - 0.83 - IMO 
0.84 0.91 0.91 0.95 0.86 
1.01 1.06 1.01 1.07 1.05 
1.08 0.89 1.09 1.08 1.13 
1.13 1.02 1.10 1.12 1.15 
1.26 1.13 1.31 1.26 1.30 
Mean difference 
from (a) -0.02 0.00 +0.02 +0.02 
25. 
Estimation of total AA usinL 2:4-dinitropheulh,ydrazine. 
The determination of total AA in biological materials by 
the method of Roe & Kuether involves the following procedures; 
(a) preparation of extracts, (b) oxidation of AA, (e) incubation 
with 2:4- dinitrophenyihydrazine to form the ozazone, (d) colour 
development with H2SO4 and (e) colorimetry of the resulting 
red brown material. Each of these procedures has been examined 
critically using human plasma and in some instances urine. 
(a) Preparation of the extract. 
Trichloroacetic acid, 6% and metaphosphoric acid, 3% were 
tested for their suitability as media for carrying out the 
dinitrophenyihydrazine procedure. To 1 vol. of plasma was 
added 3 vol. of 6% trichloroacetic acid, mixed thoroughly, 
allowed to stand for 10 min. and then filtered. Metaphosphoric 
acid filtrates were prepared by adding 2 vol. of plasma to 3 vol. 
of 3% metaphosphoric acid, mixed, stood for 10 min. and filtered. 
To 4 ml. of the filtrate was added 1 ml. of 30% trichloroacetic 
acid so that the final concentration of trichloroacetic acid was 
the same as in the trichloroacetic acid filtrates. Both 
filtrates were then treated with charcoal, dinitrophenyihydrazine 
and H2SO4 as in the original Roe & Kuether method. The mean 
difference between the total AA estimated in 17 plasma precipitated 
with trichloroacetic acid and those precipitated with metaphos- 
phonic acid was 0.02mg/100ml. (range -0.21 to 10.09) (Table 8 
column a & b). Thus precipitation of the plasma proteins 
with metaphosphoric acid instead of with trichloroacetic acid 
TABLE 9. The effect of charcoal on the recovery of AA 
added to plasma filtrates 
Percentage recovery 
Material 0.25g.charcoal 0.45g.charcoal 0.9g.charcoal 
Plasma filtrate 
+ 1.0mg AA /100ml 103 102 100 
Plasma filtrate 
+ 2.0mg AA /100ml 106 101 98 
26. 
caused a slight lowering of the AA content. It was necessary 
to add trichloroacetic acid to the metaphosphoric acid filtrate 
to ensure the oxidation of AA. 
Oxidation of AA. 
The effect on the recovery of AA added to trichloroacetic 
acid filtrates of plasma of adding different amounts of charcoal 
was examined. The amounts added were 0.45 g. as originally 
suggested by Roe & Kuether and quantities twice and one -half 
this amount. (Table 9). The recoveries of 1 mg. and 2 mg. /100m1. 
AA using 0.25 g.charcoal were respectively 1% and 5% higher than 
when 0.45g.charcoal was used. The recoveries were 2% and 2.5% 
lower When 0.9 g. was used. It seems likely therefore that a 
small quantity of AA may be oxidised beyond EKG or that it may 
be adsorbed onto the charcoal if too much is used. Either 
alternative would lead to an under estimation of AA. On the 
other hand, charcoal may remove a small amount of interfering 
substance which would also account for the higher recoveries of 
AA when the smaller quantities of charcoal were added. Adding 
the charcoal to the trichloroacetic acid before adding the 
plasma did not interfere with the estimation of total AA. 
(Table 8 columns a & c). On the basis of these results it was 
decided to omit filtration before adding the charcoal. 
Oxidation of AA by indophenol in metaphosphoric acid 
extracts of plasma was compared with charcoal oxidation of AA 
in trichloroacetic acid filtrates, using the Bolin & Book 
method of indophenol oxidation. A slight modification, in which 
one drop of cone. thiourea replaced the 2 ml. of metaphosphoric 
27. 
acid - thiourea reagent was used to reduce the final volume by 
one -half, did not alter the recovery of added AA. The total 
AA in 16 plasmas measured bypthe Bolin & Book method and the 
modification of it are compared with the values obtained by the 
Roe & Kuether method in Table 8. The mean difference from the 
values obtained by the Roe & Kuether method was {0.02mg. /100m1. 
for both the Bolin & Book method and its modification, (range 
-0.02 tot0.10 and -0.03 to f0.05 respectively). Indophenol 
oxidation of AA in metaphosphoric acid filtrates may therefore 
slightly overestimate the total AA content. 
Incubation procedure. 
The rate of coupling of AA derivatives with dinitrophenyl- 
hydrazine was tested by incubating trichloroacetic acid filtrates 
of plasma and urine after charcoal incubation for times up to 
6 hr. The rates were compared with the coupling rate of a 
standard solution containing 1 mg. /100m1. AA which had been 
treated in exactly the same way. (Fig.17). Six replicates of 
the charcoal treated filtrates of plasma, urine and the standard 
treated with thiourea and dinitrophenylhydrazine were placed in 
the incubator at 37 °C. One replicate of each was withdrawn 
after 0.5, 1, 2, 3, 4, and 6 hr., cooled immediately in ice and 
H2SO4 was added. After 0.5 hr. the optical density of the 
resultant red brown colour was read at 540 mp and the results 
are plotted against time in Fig.17. In the first half hour 
of incubation the rates of coupling with dinitrophenylhydrazine 
were the same in urine and plasma, but thereafter the rate of 








Fig.17. The rate of formation of the dinitrophenylhydrazine 
derivatives in an AA solution, in a plasma filtrate and in diluted 
urine. A, AA ( lmg. /100m1.); B, plasma filtrate; C, diluted urine. 
TABLE 10. The effect of duration of incubation on the total AA 
content of plasma and urine Results as mg./100m1. 
Hours of incubation 0.5 1.0 2.0 3.0 4.0 6.0 
Plasma total AA 0.63 0.62 0.62 0.64 0.64 0.64 
Urine total AA 0.63 0.55 0.49 0.49 0.49 0.49 
TABLE 11. The effect of temperature of incubation on the total AA 
content of plasma Results as mg. /100m1. 
Incubation temp. 37° Incubation temp. 60° Difference 
0.13 0.10 -0.03 
0.19 0.20 +0.01 
0.21 0.15 -0.06 
0.25 0.27 +0.02 
0.28 0.32 +0.04 
0.30 0.32 +0.02 
0.35 0.35 0.0 
0.37 0.37 0.0 
0.38 0.38 0.0 
0.4.0 0.40 0.0 
0.51 0.49 -0.02 
0.55 0.60 +0.05 
0.72 0.77 +0.05 
0.75 0.86 +0.11 
0.86 0.87 +0.01 
0.87 0.95 +0.08 
0.92 0.89 -0.03 
0.95 0.98 +0.03 
1.10 1.16 +0.06 
1.25 1.33 +0.08 
1.60 1.69 +0.09 
Range 0.13 - 1.60 Range 0.10 - 1.69 Mean = +0.025 
28. 
the ratesof coupling in plasma and the standard were the same. 
The final concentration of AA in plasma and urine calculated from 
the corresponding standard at the appropriate times of incubation 
are given in Table 10. An incubation time of 3 to 4 hr. was 
selected as the most satisfactory time for plasma and urine. 
Increasing the temperature of incubation to 60 °C and reducing 
the time from 3 hr. to 40 min. as suggested by Geschwind has 
been examined. The total AA content of 21 plasmas after 
incubation of the filtrates at 37 °C for 3 hr. and at 60 °C for 
45 min. are given in Table 11. After incubation at 60 °C the 
range of values is wider and the mean slightly higher. It was 
decided that slower incubation at 37 °C gives more consistent 
results and this procedure was adopted. 
Colorimetry 
Roe & Kuether suggested that after the addition of H2SO4 
to the incubated samples development of the brownish red colour 
should be allowed to continue for one -half hour before reading 
the optical density. The adsorption spectrum of this coloured 
material in plasma, erythrocytes and urine extracts has been 
examined one -half hr., 18 and 120 hr. after adding the H2SO4. 
The absorption spectra of the resultant colour in a standard 
solution containing 0.8mg./100m1. AA and in a plasma filtrate 
are given in curves A & B respectively of Fig.18; the corres- 
ponding blanks are shown in curves D & C. The peak absorption 
of the AA derivative, reported to be at 518 m}i, is very flat 
in curves A & B. However, subtraction of the blank curves D & 








Fig.18. Absorption spectra of dinitrophenylhydrazine derivatives. 
A, AA (0.8mg. /100m1.); B, plasma filtrate; C, plasma blank; D, 
control blank; E, B- C; F, A - D. 
29. 
AA standard. These two curves are similar in shape and are 
characteristic for the AA derivative. The stability of the 
colour, measured at 540 mp, was then examined at 18 hr. and 40 hr. 
after the addition of H2SO4 (Fig.19). The optical density of 
the plasma material (A) and its blank (E) increased slowly and 
steadily whereas there was practically no increase in the 
standard blank (F) and the standard itself (3) slowly decreased. 
Subtraction of the appropriate blanks from the plasma and standard 
values i.e. C and D, showed that there was a slight fall in the 
optical density of the AA derivative in both the standard and the 
plasma. The nature of the material in plasma which causes the 
blank reading and which slowly increases with time is not known. 
In general the plasma blank is little different from the standard 
blank in the first half hour after adding the H2SO4. 
The absorption spectra and the stability of the derivatives 
in urine were then examined. The optical density at 540 mp of 
a concentrated urine (total AA equivalent to 12 mg. /100m1) and 
of a blank prepared from it, were measured at intervals up to 
120 hr. (Fig.20) . The colour of the urine blank read at 0.5 
hr. after the 'addition of °-í2SO4 was equivalent to 2 mg. /100m1. 
AA. After 120 hr. the optical density of the urine had scarcely 
decreased whereas the blank colour was much greater. Subtraction 
of the optical density of the blank from that of the urine after 
18 hr. showed that a considerable fading of the urinary AA had 
occurred. Similar curves were obtained for 2 other diluted 
urines (Fig.21) and again the urine blank samples contained a 
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Fig.19. The stability of the dinitrophenyihydrazine derivatives of 
AA and plasma in 85% (w /v) H2SO4. A, plasma; B, AA (0.8mg./100m1.); 








Fig.20. The stability of dinitrophenylhydrazine derivatives in urine. 
A, urine; B, urine - urine blank; C, urine blank; D, control blank 
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Fig.21. The stability of dinitrophenylhydrazine derivatives in 2 
diluted urines. Al urine 1; B, A - C; C, urine blank; D, urine 2; 
E, D - F; F, urine 2 blank. 
30 . 
That the increase in optical density of the blank is probably 
not due to a derivative formed by slow coupling of AA with 
phenylhydrazine is shown in Fig.22. The absorption spectrum 
of the blank colour 18 hr. after the addition of H2SO4 lacked 
the peak at 518 mp characteristic of the AA derivative, whereas 
the absorption spectrum of the urine derivative after subtraction 
of its blank is typical of AA even after 18 hr. These 
experiments clearly show that there is some material other than 
AA in urine which gives a slowly developing colour with phenyl - 
hydrazine. In the urine examined, this material was equivalent 
to as much as 10% of the total colour and after 120 hr. it 
accounted for one half the total. Although the colour of the 
AA derivative is stable for 4 hr. (Roe & Kuether) the most 
accurate estimate of total urinary AA is obtained only if the 
colour in the urine and the blank are measured one -half hour 
after the addition of H2SO4. In plasma, the blank colour is 
the same one -half hour after the addition of acid as that 
obtained from a tichloroacetic acid solution of AA treated in 
the same manner. However the plasma blank slowly increases 
with time and it is therefore advisable to read all the colours 
after they have developed for one -half hour. Examination of 
the absorption spectra of erythrocyte filtrates and blanks 
prepared from them showed that these solutions behaved in the 
same manner as did the plasma solutions. 
Measurement of total AA using H--S 
Many workers have suggested the use of H2S for the estimation 









Fig.22. Absorption spectra of urinary dinitrophenylhydrazine 
derivatives after 18 hr. A, urine - urine blank after 1 hr.; B, 
urine - urine blank after 18 hr.; C, urine blank after 18 hr. 
TABLE 12. The recovery of DHA added to plasma 
Results as mg. /100m1. 
Buffered indophenol method 
Material DHA added Before H2S After H2S 
pH 1.8 pH 3.5 
Roe method 
Plasma A None 0.82 1.06 1.10 0.88 
0.5 0.82 1.12 1.74 1.38 
Plasma B None 1.12 1.26 1.45 1.11 
0.5 1.12 1.39 2.21 1.60 
1.0 1.12 1.47 3.11 2.60 
TABU', 13. Comparison of the H2S method with the indophenol 





method after H2S at 
pH 1.8 pH 3.5 +CMB 
Roe method 
Plasma 0.63 1.01 1.01 - 0.58 
filtrates 0.88 1.00 - - 0.85 
0.59 0.70 - - 0.49 
1.02 1.22 - - 1.01 
0.99 1.15 - - 0.92 
0.16 - 0.34 - 0.14 
0.26 - 0.46 - 0.31 
0.19 - 0.59 - 0.09 
0.17 - 0.37 - 0.15 
Erythrocyte 0.45 - 0.72 0.30 0.28 
filtrates 0.39 - 0.42 0.13 0.08 
0.50 - 0.64 0.19 0.14 
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reducing activity before and after treatment with H2S allows 
both reduced and total AA to be estimated in a sample. The 
difference between these two values is also used to calculate 
the quantity of DHA. The interpretation of results obtained 
by this method is made difficult, however, by the fact that H2S 
reduces other materials in addition to DHA. 
In several experiments the AA content of plasma and erythro- 
cyte extracts was estimated with this method. Hydrogensulphide 
treatment of metaphosphoric acid solutions of DHA and AA buffered 
to pH 3.5 showed that 95 to 105% of these substances could be 
recovered. Very low recoveries of DHA were obtained when the 
solution was not buffered (pH approx. 1.8). The results obtained 
when known amounts of DHA were added to plasma are given in 
Table 12. Ascorbic acid was meaured by the "buffered indophenol" 
method before H2S treatment, after H2S treatment at pH 1.8 and 
3.5 and by the Roe & Kuether method. Treatment with H2S 
increased the indophenol value and at pH 3.5 the indophenol value 
was much more than the total AA value. This increase was con- 
siderably more than the theoretical increase due to the addition 
of DHA. The added DHA was not recovered after H2S treatment at 
pH 1.8. None of the solutions gave a positive nitroprusside or 
lead acetate test so that no detectable H2S remained in the 
solutions, which had had wet N2 bubbled through them for 3- hr. 
Table 13 shows the AA content of 9 plasma filtrates and 3 
erythrocyte filtrates measured by the "buffered indophenol" 
method before H2S treatment and after H2S treatment at pH 1.8 
or 3.5. The total AA measured by the Roe & Kuether method is 
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also given. For all the filtrates an increase in the indophenol 
value was observed after treatment with H2S. It is unlikely 
that this increase was entirely due to BHA because the values 
were all considerably higher than the Roe & Kuether values. 
A faint positive nitroprusside test was observed in the cell 
filtrates even after they had been treated with N2 for 3 hr. 
The last traces of H2S are probably more difficult to remove 
from cell filtrates than from plasma or standard solutions. 
It has already been shown that erythrocytes contain substances 
that react slowly with indophenol. Most probably treatment with 
H2S increases the amount of interfering materials with indophenol 
reducing activity. 
The results of these experiments were so forbidding that it 
was thought unprofitable to investigate further the H2S method. 
More suitable conditions for the procedure may exist but the 
conditions used in the above experiments are those reported in 
the literature as optimal. Application of the CMß reagent to 
H2S treated filtrates would eliminate interference due to traces 
of H2S. The results of its use with 3 erythrocyte filtrates 
after H2S treatment are given in Table 13. Most of the inter- 
ference due to S compounds, either traces of H2S or thiols formed 
by H2S reduction, has been removed. However the AA values are 
still slightly higher than those obtained by the Roe & Kuether 
method. 
The estimation of the vitamin C content of plasma erythro- 
cytes and, urine b different methods. 
In the past, opinions have differed on whether any of the 
TABLE 14. The DHA content of plasma determined by the difference 
between the Roe method and the 'buffered' indophenol method 
Results as mg. /100m1. 
Roe method 
Buffered 
method DHA Roe method 
Buffered 
method DHA 
0.03 0.09 -0.06 0.54 0.59 -0.05 
0.04 0.02 +0.02 0.55 0.49 +0.06 
0.06 0.21 -0.15 0.55 0.49 +0.06 
0.09 0.05 +0.04 0.58 0.63 -0.05 
0.09 0.19 -0.10 0.61 0.63 -0.02 
0.10 0.09 +0.01 0.64 0.55 +0.09 
0.13 0.05 +0.08 0.65 0.64 +0.01 
0.13 0.16 -0.03 0.70 0.69 +0.01 
0.14 0.16 -0.02 0.15 0.75 0.0 
0.15 0.17 -0.02 0.79 0.80 -0.01 
0.16 0.13 +0.03 0.81 0.91 -0.10 
0.19 0.14 +0.05 0.82 0.91 -0.09 
0.20 0.08 +0.12 0.84 0.89 -0.05 
0.22 0.21 +0.01 0.85 0.88 -0.03 
0.27 0.22 +0.05 0.86 0.80 +0.06 
0.28 0.23 +0.05 0.87 0.87 0.0 
0.29 0.27 +0.02 0.92 0.91 +0.01 
0.29 0.19 +0.10 0.95 0.95 0.0 
0.30 0.40 -0.10 0.95 0.99 -0.04 
0.31 0.26 +0.05 1.01 1.08 -0.07 
0.35 0.32 +0.03 1.01 1.02 -0.01 
0.36 0.36 0.0 1.08 1.07 +0.01 
0.37 0.40 -0.03 1.08 1.14 -0.06 
0.38 0.31 +0.07 1.10 1.04 +0.06 
0.40 0.40 0.0 1.10 1.09 +0.01 
0.41 0.45 -0.04 1.13 1.16 -0.03 
0.44 0.45 -0.01 1.20 1.13 +0.07 
0.44 0.44 0.0 1.26 1.30 -0.04 
0.49 0.59 -0.10 1.37 1.40 -0.03 
0.51 0.50 +0.01 1.57 1.33 +0.24 
0.51 0.35 +0.16 1.60 1.75 -0.15 
Mean = +0.002 
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vitamin C in blood exists in the oxidised state i.e. as dehydro- 
ascorbic acid. Until 1943 when Roe & Kuether suggested their 
phenylhydrazine method, the vitamin had been estimated as total 
AA by the H2S method. This method, as has just been shown, 
cannot be considered sufficiently reliable as a means for calcu- 
lating the DHA content of tissue extracts; more so because the 
analysis necessarily. epends on a determination by difference. 
It is at present generally agreed that a small fraction of blood 
vitamin C is present as DHA. However in the absence of a specific 
chemical method for the estimation of DHA any statement of the 
actual amount of DHA present in blood or its constituents must be 
regarded with much caution. 
(a) Plasma 
In the course of the present investigation the AA content of 
a number of plasmas (heparinised or oxalated) from normal subjects 
was determined by several methods. In Table 14 are presented 
the analyses of 62 plasmas by the "buffered indophenol" method 
and by the Roe & Kuether method. DHA is calculated by difference 
The mean DHA found in this series was 0.002 mg. /100m1. (S.D.: 0.07, 
range -0.15 to +0.24.) The total AA content ranged from 0.03 
to 160 mg. /100m1. with a mean of 0.59. The mean difference 
between the AA content measured by the buffered and the Roe & 
Kuether method was not significant, (t- 0.05,n =62, p =0) . The 
correlation coefficient (r =0.046) was not significant, so that 
there was no measurable DHA at any plasma level of total AA. 
The same statistical tests were applied to a series of 49 
plasmas (Table 15) in which the total AA was measured by the 
-TABLE 15. The DHA content of plasma determined by the difference 
between the Roe method and the 'unbuffered' indophenol method 
Results as mß. /100m1. 
Unbuffered 
Roe method: method DHA 
Unbuffered 
Roe method method DHA 
0.04 -0.05 +0.09 0.61 0.56 +0.05 
0.09 -0.14 +0.23 0.65 0.58 +0.07 
0.13 -0.01 +0.14 0.70 0.70 0.0 
0.19 0.15 +0.04 0.75 0.75 0.0 
0.20 -0.02 +0.22 0.79 0.67 +0.12 
0.22 0.16 +0.06 0.81 0.85 -0.04 
0.27 0.16 +0.11 0.82 0.85 -0.03 
0.29 0.11 +0.18 0.84 0.80 +0.04 
0.30 0.20 +0.10 0.85 0.75 +0.10 
0.35 0.36 -0.01 0.87 0.87 0.0 
0.36 0.24 +0.12 0.92 0.88 +0.04 
0.37 0.27 +0.10 0.95 0.85 +0.10 
0.38 0.46 -0.08 0.95 0.88 +0.07 
0.40 0.33 +0.07 1.01 0.91 +0.10 
0.41 0.29 +0.12 1.01 1.06 -0.05 
0.44 0.44 0.0 1.08 1.08 0.0 
0.44 0.35 +0.09 1.08 1.10 -0.02 
0.44 0.33 +0.11 1.10 1.03 +0.07 
0.49 0.43 +0.06 1.10 1.09 +0.01 
0.51 0.35 +0.16 1.13 1.12 +0.01 
0.51 0.10 +0.41 1.20 1.10 +0.10 
0.54 0.63 -0.09 1.26 1.29 -0.03 
0.55 0.32 +0.23 1.37 1.35 +0.02 
0.55 0.50 +0.05 1.60 1.75 -0.15 
0.58 0.50 +0.08 
Mean = +0.06 
34. 
Roe & Kuether method and the reduced AA was measured by the 
"unbuffered indophenol" method. In this series the mean DHA 
was 0.065 mg. /100m1. (S.D. 0.09, range -0.15 to 40.41). The 
estimation of AA by the unbuffered method gave values which were 
significantly lower (t =5, n =49, p= <.001) than those obtained 
by the Roe & Kuether method. There was a significant negative 
correlation (r: -0.36) between the total AA values (mean 0.59, 
range 0.04 to 1.60) , and the calculated DHA values. 
When the concentration of total AA in plasma was 0.2mg. /100m1. 
or less, the optical density measured by the "unbuffered indophenol" 
method of the filtrates was greater than the optical density of 
the blank solution and extrapolation of the standard curve beyond 
zero gave the values unbuffered indophenol analyses 
shown in Table 15. These negative values are undoubtedly due to 
the difference in the rates of fading of indophenol at low pH in 
the plasma solution and in the standard solutions, as shown 
earlier in Figs. 2 & 8. Because the pH of metaphosphoric acid 
extracts of plasma is probably slightly higher than that of 
metaphosphoric acid solutions of the standards, the rate of fading 
of indophenol added to the solutions is less in the former than 
in the latter. This effect is more obvious when the AA concentra- 
tion is very low since there is insufficient AA present to cause 
a partial stabilisation of the dye. The difference between the 
Roe & Kuether and the "unbuffered" values is therefore unlikely 
to be a true measure of the DHA content, particularly when the 
AA concentration is very low. 
TABTT 16. Comparison of methods for the determination of vitamin C 
in erythrocytes 
Results as mg. /100m1. 
Apparent AA Total AA DHA 



























































Mean 0.47 0.25 0.22 0.31 0.06 
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(b) Erythrocytes 
In a smaller series of experiments the vitamin C content of 
human erythrocytes (saturated with CO) was determined using the 
Roe & Kuether "buffered indophenol" and the CMB methods (Table 16.) 
In every instance, except one, the "buffered indophenol" method 
gave values which were considerably higher than those obtained by 
either the Roe & Kuether or the CMB methods. These higher values 
are undoubtedly due to the presence in erythrocytes of interfering 
materials which react with indophenol. When these substances were 
removed by treatment with CMt3 more valid AA values were obtained. 
The mean DHA (calculated by subtracting the CMB value from the Roe 
& Kuether value) for this series was 0.063mg./100m1. (S.D. = 0.09, 
range -0.02 to +0.27.) A significant positive correlation, 
r= +0.903, of the DHA with the total AA (mean 3.68mg./100m1., 
range 0.08 to 1.19) was found. The estimation of AA by the 
CMB method gave values which were significantly lower than those 
given by the Roe & Kuether method (t 2.431, n = 12) indicating 
that by the use of these two methods a significant amount of the 
total AA in erythrocytes may be DHA. The use of the indophenol 
method without treatment with CMB is of no value as a method for 
determining the AA content of erythrocytes. 
(c) Urine. 
It was considered of interest to examine the vitamin C 
content of a small number of urines by some of the different 
methods in order to see if any of the total AA was excreted as 
DHA. The AA content of diluted urines determined by 5 different 
methods is given in Table 17 but because so few urines were 
TABLE 17. Comparison of the methods for the determination of 
vitamin C in diluted urine 
Results as mg. /100m1. 
Apparent AA Total AA 
':Buffered method' :'Unbuffered method' _CIM method HOHO method Roe method 
0.31 _ 0.13 - 0.36 
0.47 - 0.36 - 0.43 
0.53 - 0.42 - 0.42 
0.28 - 0.25 - 0.32 
0.19 - 0.02 - 0.14 
0.48 0.67 - - 0.26 
1.57 2.1 - - 1.39 
0.45 0.52 0.60 0.05 0.50 
1.12 1.28 1.55 0.97 1.31 
0.37 0.69 0.58 0.97 0.51 
0.98 1.32 0.82 0.42 0.46 
0.69 0.94 0.68 0.04 0.60 
0.22 0.30 0.24 0.30 0.59 
1.95 - - - 1.49 
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examined only tentative conclusions can be drawn. Comparing 
the results obtained by using the "buffered indophenol" the CMB 
and the formaldehyde methods with those using the Roe & Kuether 
method it was found that they did not differ significantly 
(t = 0.33, 0, and 0.58 respectively). The "unbuffered indophenol" 
method however gave values which were significantly higher than 
the Roe & Kuether values (t = 5.1). It is known that both the 
"unbuffered" and the "buffered indophenol" methods over- estimate 
the AA content of urine because urine contains interfering 
materials which react with indophenol. Some but not all the 
interfering material can be suppressed by the use of CMB. 
In a larger series in which only CMB and "buffered indophenol" 
methods were compared it was found that the former method gave 
values which were 15% lower. The formaldehyde method is 
reported to remove most of the interfering materials and it was 
thought that this method might give lower values than either the 
buffered or unbuffered methods. Significantly lower values 
were not however obtained probably because of the greater 
technical difficulties of the method. Probably very little 
DHA was excreted in the urines examined. 
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DISCUSSION 
Reduction of indophenol is the most widely used method for 
the measurement of the AA content of mammalian tissues. The 
inherent difficulties of the method due to the fact that indophenol 
is reduced by substances other than AA have not always been 
realised. Van Eekelen & Emmerie (1936) suggested the removal of 
interfering substances by precipitation with mercuric acetate. 
Their subsequent removal of excess mercuric ions with H2S, 
however, introduces a further source of error. King (1936) 
has stated that interference caused by glutathione and some other 
substances can be eliminated if the reaction is carried out in a 
strongly acidic medium. On the other hand it has been shown by 
Mindlin & Butler (1937-38) and confirmed in the course of this 
investigation that indophenol itself fades considerably at low 
pH. Ónly when the pH is above 4 does the spontaneous fading of 
eN 
the dye become inappreciable. That AA contributes some 
stabilising effect to the fading of indophenol has been shown by 
Mindlin & Butler (1937 -38), Lugg (1942) and Stewart, Horn & 
Robson (1953). The stabilisation is however only temporary 
and at concentrations less than 1 mg. /100m1. it is not completely 
effective even for a very short time (5 min.) Since the AA 
content of human plasma and erythrocytes is usually less than 
t_is it would seem more advantageous to raise the pH to a value 
where fading of indophenol does not occur i.e. pH 4, than to 
rely on the small amounts of AA present for stabilisation. 
Furthermore the addition of plasma or a solution of AA to 3% (w /v) 
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metaphosphoric acid does not result in filtrates of identical low 
pH so that the fading of indophenol with test solutions prepared 
in this way does not proceed at the same rate as in corresponding 
standard solutions. By raising the pH to 4 this source of error 
can be eliminated. The only advantage to be gained by measuring 
the decolorisation of indophenol by AA at low pH is the suppression 
of fading due to interfering substances such as glutathione. 
However, the interference due to some other substances e.g. 
ergothioneine and thiosulphate is greater at low pH. Evelyn 
et al. (1938) suggested that a correction for the fading at pH 4 
due to interfering substances in urine could be made by taking 
successive measurements of indophenol reducing activity and extra- 
polating to zero time. Since this procedure involves a curvilinear 
and not a linear extrapolation very considerable errors may be 
introduced. 
A better approach to this problem is therefore to measure 
the decolorisation of indophenol at a pH greater than 3.5 and 
devise a procedure for the removal of the interfering substances. 
For this purpose Lugg (1942) proposed the use of formaldehyde 
which will condense with both AA and many interfering substances to 
an extent which depends on the pH. AA condenses slowly with 
formaldehyde at pH 1.5 and rapidly at pH 3.5. Most interfering 
substances except reductones and hydroxytetronic acid condense 
rapidly at pH 1.5. After condensation at pH 1.5 and 3.5 the 
difference in indophenol reducing activity gives a measure of the 
Aà content in the absence of reductones and hydroxytetronic acid. 
The latter substances are probably not present to any extent in 
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plasma and erythrocytes. Modifications of this procedure have been 
used for the determination of AA in urine by Mapson (1953) and by 
McSwiney, Clayton & Prunty (1954). However Snow & Zilva (1944) 
have pointed out that careful control of the conditions for the 
condensation is needed and the procedure itself is extremely 
laborious (Mapson & Harris, 1947). 
The recoveries of added AA are lower when estimated by the 
formaldehyde method than when using the standard indophenol 
procedures. The formaldehyde method can therefore be used 
successfully only when the AA content is relatively high ß.g. in 
urine, ( McSwiney et al., 1954) whereas in blood the AA concentration 
is too low for the method to be used with advantage. 
Many of the substances whichaause slow fading of indophenol 
contain sulphur. The presence of such substances e.g. glutathione, 
cysteine and ergothioneine has been demonstrated in blood and other 
mammalian tissues and these substances are usually blamed for the 
slow fading of indophenol in mammalian tissue extracts (Bessey, 
19381 King, 1941). It is well known that CMB forms complexes 
with thiols (Barron & Singer, 1945) and this substance_ is frequent- 
ly used as a specific -SH inhibitor. It was thought therefore 
that the use of C1tB might be a satisfactory means of increasing 
the specificity of the indophenol method for AA. Preliminary 
experiments showed that CM.B did not interfere with the indophenol 
method when it was applied to aqueous solutions of A.A. A linear 
standard curve was obtained with AA solutions containing 50 mg. /100ml. 
of CMB. When CMB was added to solutions of glutathione, cysteine, 
ergothioneine, homocysteine, 2:3- dimercaptopropanol, hydrogen 
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sulphide, thiouea and thiosuiphate it completely inhibited the 
indophenol reducing activity of the compounds. This inhibition 
persisted for at least 5 min. Although the indophenol reducing 
activity of sodium sulphite was not completely inhibited it was 
considerably reduced by CMB. The effect of CMB on the indophenol 
reducing activity of metaphosphoric acid extracts of plasma, 
erythrocytes, urine and rat liver to which glutathione, cysteine, 
íí2S, and thiosuiphate had been added, was then examined. CMB 
again completely inhibited the indophenol reducing activity of 
these compounds but did not affect the recovery of AA added to 
the extracts. 
The effect of OMB on the indophenol reducing activity of 
protein -free filtrates of human plasma, erythrocytes and urine 
and of rat liver and kidney was next examined. CMB had a 
negligible effect on the activity of plasma filtrates. However 
slow decolorisation of indophenol was absent in these filtrates 
which confirms the previously reported absence from plasma of 
substances which interfere with the indophenol reaction. 
Metaphosphoric acid extracts of erythrocytes, urine, liver and 
kidney all contain appreciable amounts of substances which react 
slowly with indophenol, Treatment with CMB completely inhibited 
the slow decolorisation of indophenol by the filtrates of erythro- 
cytes, liver and kidney. Presumably the interfering substances 
in these tissues consist chiefly of S.- compounds e.g. glutathione 
and ergothioneine. The fact that no progressive decolorisation 
of indophenol occurred after the addition of CMB to these extracts 
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suggests that the results obtained by this procedure represent 
the actual AA content. The possibility must be considered 
that interfering materials which react rapidly with indophenol 
and are not inhibited by CMB are also present. Mapson & Harris 
(1947) using a "continuous flow" method for the estimation of AA 
reported that of a wide range of substances tested only hydroxy- 
tetronic acid reacted with indophenol at the same rate as AA 
under similar conditions of pH. 
Slow decolorisation of indophenol also occurred with filtrates 
of urine; this was only partly inhibited by CMB. Mapson (1953) 
has shown that two groups of interfering substances are present 
in urine. One group, the S- compounds, rapidly forms complexes 
with HCHO at pH 0.6. This is the group inhibited by CMB. The 
second group reacts slowly with HCHO at pH 3.5 but not at all at 
pH 0.6; the nature of these substances is not known. It is 
assumed that the second group of substances corresponds to the 
material not inhibited by CMB and to the material which Evelyn 
et al. (1938) found to be unaffected by mercuric acetate. Since 
CMB does not remove all the interfering material present in urine, 
the formaldehyde method may provide a more accurate method for the 
estimation of AA in urine. 
It is concluded that preliminary treatment of tissue extracts 
with CMB greatly improves the specificity of the indophenol reaction 
for the estimation of AA in some biological tissues. The procedure 
suggested provides a simple, specific method for the measurement of 
AA in erythrocytes liver and kidney but when applied to urine 
includes a small amount of interfering material. 
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The formation of a dinitrophenylhydrazine derivative as 
suggested by Roe & Kuether (1943) provides a method which is 
specific for AA and its derivatives. The manipulationsrequired 
for its use in the separate determination of AA, DHA and DKG 
(Roe et al., 1948) are, however, cumbersome. For the measurement 
of reduced and total AA therefore the simplest procedure to use is 
a reliable indophenol method and the Roe & Kuether (1943) method. 
None of the modifications of the original Roe & Kuether 
method offer any advantages in the determination of total AA in 
plasma and erythrocytes. When metaphosphoric acid was used in 
blace of t.richloroacetic acid for the precipitation of protein 
slightly lower values were obtained, indicating that oxidation was 
not complete in these extracts. On the other hand, when indophenol 
was used in place of charcoal as an oxidising agent in metaphosphoric 
acid extracts, as suggested by Bolin & Book (1947), slightly higher 
values were obtained. The quantity of charcoal used for the oxid- 
ation has a slight effect on the recovery of AA added to plasma 
filtrates. If too little charcoal is used slightly higher results 
are obtained. In contrast when larger quantities of charcoal 
were used the percentage recovery of added AA was less. These 
results may be explained either by the assuption that a little AA 
is absorbed onto the charcoal or that some oxidation beyond DHA 
occurred. The charcoal itself may remove a small amount of 
interfering material. 
Increasing the temperature of the coupling to about 60c as 
suggested by Geschwind et Al. (1951) gave somewhat less consistent 
results and its only advantage is the saving of time. Further 
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increase of the temperature to 100 °C for 5 min. (Meyer, Haselbach 
& Boissonnas, 1952; Shaffert & Kingsley, 1955) could result in poor 
reproducibility since small errors in the time would be important. 
This has been demonstrated by Glick, Alpert & Stecklein (1953). 
The omission of thiourea and the use of glacial acetic acid 
in place of 85% H2SO4 (Bolomey & Kemmerer, 1946, 1947) was soon 
refuted by Mills & Roe (1947) who pointed out the necessity for a 
reducing substance to prevent interference in the final colour 
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development by oxidants such as Fe,, and H202. Interference 
by sugars auch as glucose and fructose is diminished by the use 
of 85% H2SO4, in which medium, the derivatives of the sugars fade 
in half an hour to such a low level that they cause practically 
no interference at a wavelength of 540 my. 
It has been confirmed that the peak absorption of the 
ascorbic acid derivative is at 518 my and that in plasma, erythro- 
cytes and urine any absorption due to interfering substances 
occurs at lower wavelengths. The optical density of the interfer- 
ing substances increases slowly with time whereas that of the 
ascorbic acid derivative decreases. This phenomenon is most 
evident in urine extracts where the colour of the interfering 
materials can account for as much ag 10% of the total colour 
developed after half an hour and after 120 hr. it may represent 
50% of the total colour. That this increase in colour is not 
due to slow coupling with AA in the blank solution was shown by 
the absence of the characteristic AA peak at 518 mu even after 
120 hr. Furthermore, standard AA solutions to which dinitro- 
phenylhydrazine was added after incubation did not increase at 
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this rate. Although the AA derivative is reported by Roe & 
Kuether (1943) to be stable for 4 hr. it seems advisable to read 
the optical density of the urine solutions not later than half 
an hour after the addition of the acid. 
The only other widely used method for the determination of 
total AA depends on the reduction of DHA by H2S and the subsequent 
measurement of the total indophenol reducing capacity. Serious 
doubt is cast on the validity of this method since H2S itself 
reduces indophenol and although the last traces of H2S can be 
removed from metaphosphoric acid solutions of pure DHA by treatment 
with wet N2 for 3 hr., even after a much longer time some H2S may 
remain in tissue extracts. Furthermore many workers have reported 
that treatment 6f tissue extracts with H2S may produce interfering 
material not present originally (Johnson, 1933; Mack & Tressler, 
1933; King, 1936; Kellie & Zilva, 1936; Bessey, 193$b). In the 
present investigation it was found that treatment of filtrates of 
plasma and erythrocytes resulted in AA values considerably higher 
than those obtained by the Roe & Kuether method. These values 
therefore could not represent the true AA content of the extracts. 
Similar findings on the presence of increased amounts of interfering 
substances in whole blood (Butler & Cushman, 1940) and in urine 
(Evelyn et al. 1938) after treatment with H2S have been reported. 
The validity of the H2S method can be greatly improved by the 
use of CMB which completely inhibits interference due to traces of 
H2S and thiol compounds. However since the Roe & Kuether method 
already provides a specific method for the determination of total 
AA (i.e. AA f DHA s DKG) the only useful application of the H2S 
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method combined with the CMS, method would seem to be for the 
estimation of the AA 4 DHA as distinct from the DKG which is not 
reduced by H2S and is reported to have no anti -scorbutic activity. 
Widely divergent views have been held on the amount and even 
the existence of DHA in blodd or its components. It is almost 
certain that these differences rest on the technical difficulties 
of the methods used in its determination. 
Most workers agree that some AA in plasma becomes oxidised 
if the sample is allowed to stand for any length of time. The 
analyses must be carried out as soon as possible after withdrawal 
of the blood and if protein precipitation is not achieved within 
0,5 hr., the results must be viewed with suspicion. Practically 
all the methods which have been used for the estimation of AA give 
good recoveries of added AA. However recovery tests, while 
valuable as a check, do not provide information as to whether 
interfering materials are included but only show that the method 
will estimate the added AA. Evidence on the suitability of 
methods needs therefore to be checked rigorously. 
Since no simple, specific, chemical method is available for 
the determination of DHA in biological tissues its estimation 
depends upon the difference between the values obtained for 
reduced and total AA. These differences are vanishingly small. 
Furthermore DHA is unstable at the pH of blood so that any figure 
for the quantity of DHA in blood must be stated with caution, 
particularly if the total AA is low. 
Some early workers believed that most of the vitamin C in 
blood serum or plasma was exclusively DHA (Plant & Bulow, 1935; 
TABLE 18. The DHA content of blood as reported by other authors. 
Authors Material AA method Total AA method MIA values 
Van Eekelen & serum titration H2S None 
Emmerie (1936) 




titration H2S None 
Borsook et al. plasma titration H2S None 
(1937) 




Lowry et al. serum spectrophotometric Roe o to 0.09 
(19457- 
Lloyd et al. plasma spectrophotometric Roe 0.1 to 0.3 
(1945` 
Daubenmerkl serum spectrophotometric Roe 0.15 
(1949) 
Todhunter et al. serum spectrophotometric Roe None 
(1950) - - 
Chen & Schuck blood not stated not stated Some DHA 
(1950) 
Davey et el. serum 
plasma 
titration Roe 0 to 0.15 
(1952r 
Damron et al. g.pig 
blood 
Roe et al.(1948) Roe et al. (194? 0.03 
(1952)~ 
-
M.R.C. Report plasma spectrophotometric Roe 0 to 0.18 
No 280 (1953) 
Stewart et al. plasma spectrophotometric Roe 0.07 to 0.34 





micro- titration H2S 0.09 
McSwiney et al. plasma titration Geschwind et al. 0 to 1.0 
(1954) 
-






modifications of Roe 0.9 to 1.0 
Serum 0.4 
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Fujita & Ebihara 1937 ?. The conclusions and the chemical methods 
which have been used by different workers to derive Drib. values are 
set out in Table 18. Comparison of the results is difficult since 
different methods of analysis have been employed. That all the 
AA in plasma is in the reduced form was reported by Kellie & Zilva, 
(1936), Borsook, Davenport, Jeffreys & Warner (1939) and Farmer 
& Abt (1936). However these studies were carried out before the 
Roe & Kuether method was developed so that total AA was measured 
by the H2S method and the reduced AA was measured by the titration 
procedures. Both the latter methods may be subject to serious 
errors. Todhunter et al. (1950) found no significant difference 
between values for serum obtained by a photoelectric indophenol 
method and the dinitrophenylhydrazine method of Lowry, Lopez & 
Bessey (1945). The latter group also found that these methods 
gave similar results. 
11 ore recently up to 0.34 mg. /100m1. or 28% of the total AA 
has been reported to be present in plasma or serum as DHA. 
Several investigators (Davey et al. 1952; McSwiney et al. 1954; 
Banerjee & Belvady, 1953) have used a titration procedure for 
estimating reduced AA. Sulpho ®salicylic acid was used as the 
protein precipitant by the latter group and this reagent is not 
regarded as satisfactory for AA analyses. That the differences 
observed between the total and reduced AA may result from the 
time delays before analysis of the specimens and are not due to 
the preformed DHA has already been suggested by Lloyd et al. 
(1945) and Daubenmerkl (1949). It is unfortunate that an 
"unbuffered indophenol" method was used in the careful study of 
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Stewart et al. (1953). The only investigations in which the 
dinitrophenylhydrazine method was used for both total and reduced 
AA have given widely differing results. Roe and his collaborators 
found only 0.03 mg. /100m1. DHA and no DKG in guinea pig blood, 
whereas Schaffert & Kingsley (1955) using a modification of the 
Roe procedure found the highest values yet reported for DHA. 
However they used a termperature of 100 °C for 5 min. for the 
coupling procedure, a practice which has been severely criticised 
by Glick, Alpert & Stecklein (1953). Chen & Shuck (1950) 
reported that they found DHA in blood but give no details of their 
methods or other values they obtained. 
In the present investigation it has been found that no 
significant difference exist between AA analyses of plasma carried 
out by the "buffered indophenol" method and by the Roe & Kuether 
procedure. It is therefore concluded that no measurable DHA 
exists in human plasma when these methods are employed. However 
when the AA was measured by the "unbuffered indophenol" method, 
the mean DHA was 0.065 mg. /100m1. Furthermore, a significant 
negative correlation was found between the total AA and the DHA. 
This is attributed to the known inaccuracy of the "unbuffered 
indophenol" method when the total AA content is low. It is 
considered that the "buffered indophenol" method gives a more 
reliable indication of the AA content and by derivation, therefore 
of the DHA. 
Indophenol methods were quite unreliable when used on 
erythrocyte filtrates unless interfering materials were removed 
by CMB. The mean DHA calculated by the difference between the 
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CMB and. Roe & Kuether values was 0.063mg./100m1. A significant 
positive correlation was found between the DHA and the total AA 
content. The lack of specificity of the indophenol method when 
used to estimate the AA content of erythrocytes, in which there 
are large amounts of interfering material, probably accounts for 
the absence in the literature of any estimate for the DHA content 
of erythrocytes. 
Both DHA and DKG have been reported in urine (Penney & Zilva, 
1943). In normal urine the presence of large amounts of interfer- 
ing materials makes the use of the indophenol method for estimating 
reduced AA impracticale unless special procedures are used to 
remove them. Mapson (1953) examined the AA content of urine by 
indophenol titration, by the Roe & Kuether method and by the 
formaldehyde method. He obtained reasonable agreement between 
the dinitrophenylhydrazine and formaldehyde results though the 
latter usually yielded slightly lower values. The dye titration 
method gave results approx. 10 times greater. In the present 
investigation it was found that urine sometimes contains consider- 
able amounts of interfering materials which react with dinitro- 
phenyihydrazine. In those urines in which the vitamin C was 
estimated by the Roe & Kuether method, the "unbuffered indophenol", 
the CMB and theHCHO methods, the "unbuffered" results were much 
higher than the Roe & Kuether figures. In a larger series of 
experiments the "buffered" method was compared with CMi3 method. 
CMB reduced the values by 15% and even so all the interfering 
material: was not removed. On the basis of these experiments 
it was decided that there was insufficient data to make any 
estimate of the amounts of DHA and DKG in urine. 
SECTION II. 
The reduction of dehydroascorbic acid by 
erythrocytes 
A. The reduction mechanism 
B. The reduction mechanism in various diseases 




DHA is an extremely unstable substance in aqueous solution, 
particularly at pH above 7. Nevertheless it is clear from the 
results of the numerous studies on the role of AA and DHA in a 
wide variety of biological processes that DHA is of importance 
in metabolic reactions. Even before the structure of AA was 
completely elucidated it was recognised that the reversibly oxidised 
form of vitamin C was an anti- scorbutic substance (Zilva, 1928; 
Tillmans, Hirsch & Siebert, 1932; Hirst & Zilva, 1933). More 
recent work on the bioassay of DHA using guinea pigs (Fox & Levy, 
1936; Gould & Shwachman, 1943), on the excretion of DHA in man 
(Johnson & Zilva, 1934; De Ritter, Cohen & Rubin 1951) and on 
the effect of DHA dosage on plasma levels and urinary excretion of 
AA ( Todhunter, et ál., 1950; Clayton, McSwiney & Prunty, 1954) 
confirms its anti -scorbutic properties. On the other hand, DKG 
is not anti -scorbutic (Hirst & Zilva, 1933; Borsook et al., 1937; 
Penney & Zilva, 1943,b). This fact may explain why Roe & Barnum 
(1936) found that DHA had only 25% of the activity of AA whereas 
other workers (Borsook et al., 1937; Gould, & Shwachman;1943; 
Todhunter et al., 1950) consider that DHA is uti;.ised almost as 
efficiently as AA. The preparations of the former workers may 
have contained considerable amounts of DKG. 
The administration of DHA does not raise the level of tissue 
AA as efficiently as does a comparable dose of AA (Fox & Levy, 
1936; Bulow, 1936; Damron et el., 1952). Penney & Zilva (19434 
suggested that the amount of DHA given was important and that small 
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doses were quantitatively converted to AA whereas with large doses 
there was a decrease in its utilisation. They suggested that 
delays during absorption provided greater opportunities for its 
conversion to DKG. 
Work on isolated mammalian tissues confirms the existence of 
biological mechanisms which can reduce DHA. Preparations of liver, 
kidney, adrenal and intestine readily reduce DHA (Borsook et al., 
1937; Schultze, Stotz & King, 1937 -38). Plasma however lacks this 
property (Plaut & Biilow, 1935; Schultze et al., 1937-38; Borsook 
et el., 1937). These last workers also reported that in whole 
blood no reduction occurred but since they examined only the 
plasma fraction of the blood their results are not unexpected. 
Schultze and his coworkers found that both whole blood and 
suspensions of erythrocytes reduce DHA. Lloyd (1951) and Panteleva 
(1950) have confirmed that the erythrocytes are the DHA- reducing 
components of blood. 
Ascorbic acid is also very unstable in aqueous solution 
particularly at pH above 7.0. Early workers observed that AA was 
less readily oxidised when incubated with tissue extracts than it 
was in pure solution (Quastel & Wheatley, 1934; Mawson, 1935; 
Nellie & Zilva, 1935). The existence of some stabilizing 
mechanism was postulated by Green (1933). The suggestion that 
glutathione 0S4might be involved in the protection of AA was put 
forward by De Caro & Giani (1934) and was further investigated by 
Barron, Barron & Klemperer, (1936). Mawson (1935) considered 
that cystine and cysteine might also be involved. Substances 
such as purines and creatinine (Giri & Krishnamurthy, 1941) have 
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also been suggested as "protective" agents. It is now generally 
agreed that GSH is the principle stabilising substance in 
biological materials. 
Oxidation of AA certainly occurs in biological preparations. 
Kellie & Zilva (1935) noted that, of the tissues they examined, 
washed leucocytes were outstanding in that they did not protect 
AA from oxidation. Haemochromogens also readily oxidise AA 
(Barron, De Meio & Klemperer, 1936; Lemberg, Legge & Lockwood, 
1939). This reaction depends on the presence of copper. Stotz, 
Harrer, Schultze & King in 1937 observed a slow aerobic oxidation 
of AA, added to guinea pig liver brei, which did not involve copper. 
They suggested that a cytochrome system was responsible for the 
reaction. However, no specific enzyme comparable with the AA 
oxidase which is found in plants and which catalyses the direct 
oxidation of AA by atmospheric oxygen, has been identified in 
animal tissues. Enzyme systems which indirectly catalyse the 
oxidation of AA exist in both plant and animal tissues. Little 
is known of the biological systems(if any) which convert the 
primary oxidation product DHA to DKG by opening the lactone ring. 
That the reaction is dependent on the pH has been shown by Penney 
& Zilva (1943,b). Information on the further breakdown of AA to 
oxalic acid and water is also scanty. 
There is strong evidence for an association between AA and 
GSH in biological systems. Tissues which have a high content of 
AA usually contain a reasonable amount of GSH and furthermore, 
are metabolicly active. The action of GSH in protecting AA from 
oxidation has already been cited. GSH will reduce solutions of 
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DHA without the addition of catalysts (Hopkins & Morgan, 1936). 
At physiological pH and temperature the straightforward reaction 
DHA t 2GSH AA -- GSSG 
is too slow and would require an enzyme system for it to be of 
importance in cellular respiration. Hopkins and his collaborators 
demonstrated the presence of a DHA- reductase in plants which 
catalysed this reaction. That such a system might provide a 
hydrogen transfer system analagous to the cytochrome system was 
suggested by Crook, (1941). No DHA reductase has been isolated 
from animal tissues. Schultze et al. (1937-38) concluded that 
the reduction of DHA depended on a reversible reaction with thiol 
compounds. Mawson (1935) observed that the quantity of GSH 
required for the reduction of DHA was considerably less than the 
equation required. In addition to GSH and fixed -SH groups, 
Kinkawa (1944) postulated that a reducing mechanism, which was not 
enzymic but was heat stable, existed in animal tissues. Rall 4 
Lehninger (1952) demonstrated the presence in rat liver of a GSH 
reductase which involved triphosphopyridine nucleotide (TPN). 
However they could not demonstrate the reversibility of the 
reaction 
GSSG + TPNH2 --a 2GSH -i- TPN 
In pea seedlings this reaction has been coupled with the DHA 
reductase system. The GSH reductase of plants is specific and 
does not catalyse the reduction of other disulphides such as 
cystine, nor does it involve diphosphopyridine nucleotide (DPN) 
(Mapson & Goddard, 1951). 
Indirect evidence that DPN may be involved in the reduction 
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of DHA in plant tissues has been put forward by James & Cragg 
(1943,1944). The route of hydrogen transfer may be by trio - 
sephosphate, DPN and AA. The hypothesis that systems producing 
reduced DPN may reduce DHA is supported by the work of Waygood 
(1950). Matthews (1951) has described a preparation which, in 
the presence of methylene blue or AA, catalysed the oxidation of 
DPNH by oxygen. Although the hydrogen acceptor was not DHA it was 
suggested that an intermediate such as monodehydroascorbic acid 
might function in this way. A system for the reduction of DHA 
which involves the participation of a dehydrogenase of (- hydroxy 
acids has also been postulated (James and Cragg, 1943). 
Our knowledge of the role of AA and DHA as an intermediate in 
cellular respiration has been more closely examined in plants 
than animals. No evidence exists that AA is a general respiratory 
catalyst in mammalian tissues though its reversible oxidation 
makes this a tempting hypothesis. Special oxidation processes 
in which AA plays an essential part e.g. the metabolism of tyrosine, 
have been investigated by numerous workers. Knox and le May -Knox 
(1951) have demonstrated that AA is a major dofactor in the oxidation 
of tyrosine in rat liver. It is known that AA has some function in 
the formation of intercellular materials but so far the exact role 
of AA in these processes has not been established. That AA 
enhances the enzymic conversion of folic acid to folinic acid has 
been reported by Nichol & Welch (1950) and Shive, Bardos, Bond & 
Rogers (1950). Work on the degradation of haemoglobin indicates 
that AA and oxyhaemoglobin can react directly (Lemberg, Legge, & 
Lockwood, 1941) and this reaction may be concerned with bile 
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pigment formation. 
Many workers have commented on the possibility of a relation- 
ship between AA and carbohydrate metabolism. Patterson (1949,1950) 
made the important contribution that DHA has a diabetogenic effect 
on rate. Recently liaattacharya (1955) has studied the GSH content 
of rat tissues after the administration of diabetogenic doses of 
DHA. Despite the vast literature on the relationship of AA to 
the adrenal hormones no clear picture of the function of AA in this 
field has emerged. 
The metabolism of AA in blood has not been studied intensively. 
Practically all the AA in blood plasma and erythrocytes is in the 
reduced form. It is reported however that AA does not enter the 
erythrocytes readily (Golden & Sargent, 1952). A slow transfer of 
AA into erythrocytes had earlier been reported by Heinemann (1938) 
but in 1941 the same worker showed that this was due to the presence 
of leucocytes. Panteleva (1950) observed a very slow movement of 
AA into the erythrocytes of man, horse, cat and rabbit. In the 
animal, AA must enter the cell by some process since the concentration 
of AA there can be raised by oral administration of AA. In contrast, 
it has been found that DHA readily enters the erythrocytes of human 
blood (Panteleva, 1950; Lloyd, 1951; Lloyd & Parry 1954;) and is 
there reduced. The final concentration in the cell is higher than 
in the plasma.,rythrocytes from other species e.g. horse, pig, 
dog, cat and rabbit, do not seem to be readily permeable to DHA. 
Schultze et al. (1937-38) reported that GSH and fixed -SH 
groups were responsible for the reduction of DHA by animal tissues 
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including the erythrocytes. They did not consider that there 
was any evidence for the participation of an enzyme system. 
More recent work by Thomson (1955) has shown that an enzyme 
system must be involved directly or indirectly. The system was 
sensitive to temperature, pH and heavy Metals. Dialysis destroyed 
the capacity for reducing DHA and since the addition of GSH to the 
dialysate did not completely restore the reducing activity, GSH 
or fixed -SH groups cannot be entirely responsible for the reduct- 
ion of DHA in erythrocytes. Lloyd (1954) and Thomson (1955) have 
shown that when successive amounts of DHA are added to a suspension 
of erythrocytes the total quantity of DHA which the cells can 
reduce is very large and that it is difficult to exhaust the 
reducing capacity. These findings give further support to the 
view that enzymic processes are involved. 
Little is known of the part played by the leucocytes in AA 
metabolism, except that the total AA concentration is much higher 
than that of either the erythrocytes or plasma. Lloyd (1951) has 
established that AA is taken up by the leucocytes. Both Kellie 
and Zilva (1935) and Lloyd (1951) report that leucocytes readily 
oxidise AA. 
The only report on changes in the erythrocyte reducing 
mechanism in disease is that of Thomson (1955) who showed that 
blood from patients with pernicious anaemia reduced DHA more 
rapidly than did normal blood. Factors such as diet, exercise 
and disease have been reported to affect the tissue reduction of 
DHA. Parrot and Gazave (1951) have claimed that liver from 
guinea pigs fed on a synthetic diet with no vitamin C had a low 
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DHA reducing activity which was restored by the addition of catechol. 
Training on a treadmill also increased the degree of tissue reduct- 
ion (Schroll, 1938). Vinokurov & Silakova, (1944) have reported 
a much lower than normal reducing activity Of liver from patients 
with tuberculosis and pneumonia. A similar result has been 
reported for the kidney and duodenum of patients who had died from 
tuberculosis or cancer (Matusis, 1951). However, this author found 
no abnormality in the reducing power of the pancreas and adrenals. 
During scurvy and experimental diabetes guinea pig organs appeared 
to reduce DHA more slowly. 
An enormous amount of study has beendirected towards the 
elucidation of the relation of AA to the metabolism of the adrenal 
cortex. In a comprehensive review Pirani (1952) suggests that 
the function of AA is probably non -specific and related to cellular 
activity, although many workers, on the basis of indirect evidence, 
consider that it has a specific function. A comprehensive review 
of this aspect of AA metabolism is beyond the scope of this thesis 
but some points are pertinent. Booker, Dent, Hayes, Harris & 
Green (1951) have found that both plasma and erythrocyte levels of 
AA increased when the following materials were administered to 
rats and dogs; an adrenocortical extract, cortisone and desoxy- 
cortisone. Stewart, Horn & Robson (1953) found that in man the 
parenteral administratiòn. of ACTH caused an increase in the plasma 
AA and the disappearance of any oxidised fraction of the plasma 
AA. Oral administration of cortisone similarly resulted in a 
decrease of plasma DHA but left the level of total AA unchanged. 
Vogt (1948) found that ACTH does not increase the total AA 
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content of adrenal venous blood. Lloyd & Sinclair (1953) consider, 
on the basis of Vogt's work, that ACTH could cause the oxidation of 
AA to DHA and its susequent degradation to oxalic acid. That 
cortisone causes tissues to become more reducing has been shown 
by Loxton & Le Vay (1953) who observed a fall of 25 mV in tissue 
potential 2 hours after its administration. 
Many workers have been interested in possible changes in 
ascorbib acid metabolism during disease. Studies on plasma 
levels of AA and on saturation tests have indicated that during 
some diseases, particularly tuberculosis and the collagen diseases, 
the reserves of AA in the body become depleted (Andreae & Brown, 
1946; Rhinehart, Greenberg & Baker (1936); Rhinehart, Greenberg 
& Christie (1936); Hall, Darling & Taylor, 1939; Abbasy, Gray 
Hill, & Harris (1936); Abbasy, Harris, Bllman & Gray Hill, 1937). 
A similarity between the pathological changes in chronic 
scurvy and in collagen diseases has been suggested by Rhinehart, 
Connor & Metteir (1934). Subsequent work however has failed to 
substantiate an aetiological relation between AA and the rheumatoid 
diseases (Waksman, 1949). Adrenocortical hormones are reported to 
be beneficial in the treatment of these diseases (Hensch, Kendall, 
Slocumb & Polley, 1950). Other workers have suggested that 
large doses of AA have beneficial effects in rheumatic diseases 
(Massell, Warren., Patterson & Lehmus, 1950) and in experimentally 
induced arthritis (Bacchus, 1951). The simultaneous administration 
of AA and DOCA to patients with rheumatoid arthritis was claimed 
by Lewin & Wassén (1949) to have favourable effects. This claim 
has not been substantiated by later work for either rheumatoid 
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arthritis (Spies, Stone de Maeyer & Niedermeier, 1949; Bywaters, 
Dixon & Wild, 1950; Margolis & Caplan, 1951) or for experimentally 
induced arthritis (Maclean, 1951). Little information is available 
on the effects of the simultaneous administration of AA and ACTH 
or cortisone. Hensch et al. (1950) did not find that AA enhanced 
the effect of the latter compound when given to patients with 
rheumatoid arthritis. 
The purpose of the experiments described in this section was 
three- fold:- 
A) To investigate the system which brings about the reduction of 
DHA in normal erythrocytes. 
B) To examine the effect of disease, particularly rheumatoid 
arthritis, iron -deficiency anaemia, tuberculosis and scurvy on 
the erythrocyte reducing system. 
C) To examine the effect of the administration of AA, salicylate, 




The estimation of AA. 
The "buffered indophenol" method as described in Section 1 
was found to be satisfactory for the determination of the AA content 
of metaphosphoric acid extracts of plasma and of intact and 
haemolysed erythrocytes. Since the estimations were carried out 
after the addition of large amounts of DHA (usually 10mg. /100m1.) 
considerable dilution of the erythrocyte extracts was needed and 
therefore interference due to indophenol -reducing substances 
other than AA was minimal. Dilution to bring the final concen- 
tration of AA to approximately 1 mg. /100m1. was carried out during 
the protein precipitation procedure and further dilution if 
necessary was done in the spectrophotometer cuvette. 
The estimation of AA and DHA. 
The CM3 adaptation of the "buffered indophenol" method was 
used on filtrates of haemolysed erythrocytes (prepared with 3% MPA) 
which had been treated with H2S to reduce any DHA to AA. The DHA 
content was estimated by subtraction of the indophenol value 
obtained before treatment with H2S from that obtained after H2S 
treatment. 
The estimation of total AA. 
The method used for the estimation of total AA (AA -r DHA i- DKG ) 
in plasma, haemolysed and intact erythrocytes after the addition 
of DHA was that of Roe & Kuether (1943) with the minor modification 
described in Section 1, in which filtration of the precipitated 
proteins before the addition of charcoal was omitted. Dilution 
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to bring the final AA concentration into the range of the standard 
curve was carried out during protein precipitation and again when 
the filtratès were prepared for incubation with phenylhydrazine. 
The estimation of total -SH rg sups. 
The estimation of total -SH groups in extracts of erythrocytes 
which had been haemolysed with water and to which 10 mg. /100m1. of 
DHA had been added was carried out with the help of Dr.Bhattacharya. 
The amperometric titration method of Kolthoff & Harris (1946) was 
used. No interference with the method was caused by the presence 
of AA or DHA (Bhattacharya, 1955, unpublished) . 
The estimation of reduced ridine nucleotides. 
The fluorimetric method of Levitas, Robinson, Rosen, Huff & 
Perisweig (1947) for the determination of total pyridine nucleotides 
in erythrocytes was used for the determination of reduced DPN and 
TPN in haemolysed erythrocytes to which 10 mg. /100m1. of DHA had 
been added. Pyridine nucleotides condense with acetone in 
alkaline medium to form a highly fluorescent, stable compound. 
Of the substances tested Huff and his associates found that only 
pyridine nucleotides and N- methyl nicotinamide formed the fluor- 
escent compound with acetone. Pure N- methyl nicotinamide was 
used as the internal standard. 
The fluorescence was measured in a Farrand Model A fluorometer. 
The primary filter was a Corning No.5860 filter and the fluorescent 
light was filtered through a combination of Corning No.4308 and 
No.3389 filters with maximum transmission between 4500 and 5000 A°. 
Preparation of DHA. 
DHA was prepared from AA by oxidation with an ethereal 
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solution of quinone according to the method of Patterson (1950). 
The AA was dissolved in 0.9% (w /v) saline. 
Procedure for the measurement of the rate of reduction of DHA 
by human erythrocytes. 
Intact erythrocytes. Heparinised human blood, immediately 
after withdrawal (never longer than 20 min. after withdrawal) from 
the antecubital vein, was centrifuged for 20 min. The plasma 
was removed, and the leucocyte layer discarded. The erythrocytes 
were then re- suspended in sufficient plasma, or in a mixture of 
plasma and normal saline, so that the reconstituted "blood" con- 
tained 30% (v /v) erythrocytes. Leucocyte counts were done 
occasionally and showed that it is not possible to remove the 
whole of the leucocytes. The suspension of erythrocytes was 
saturated with CO as described in Section 1. An amount of a 
saline solution containing 100 mg. /100m1. of DHA was added, 
sufficient. to give a final concentration of 10 mg./100m1. of blood. 
The blood, in a stoppered tube filled with CO, was then incubated 
at 37oC for the required time, usually 15 min., and then centrifuged 
for 10 min. at a standard speed. The plasma and erythrocytes 
were separated and precipitated for vitamin C estimations by the 
"buffered indophenol" and Roe & Kuether methods. It was found 
convenient to precipitate the erythrocytes in a graduated centri- 
fuge tube. One ml. of erythrocytes was measured into the tube 
and into it the precipitating acid was pipetted. Thorough mixing 
was achieved by stirring with a glass rod and then the tube was 
corked and inverted several times. Because of the manipulations 
required, it was difficult to measure the reduction rate at times 
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less than 30 min. after adding the DHA. 
Haemolysed blood. Three volumes of RBC, separated so far as 
possible from the other blood components, were haemolysed with 
7 vol. of water. The solution was saturated with CO and DHA 
added to give the required concentration. Aliquots of the 
haemolysed solution were withdrawn at specified times and 
precipitated with metaphosphoric acid for the "buffered indophenol" 
and H2S methods, and with trichloroacetic acid for the Roe method. 
Using this procedure it was possible to measure the rate of 
reduction immediately and at intervals of 5 min. after the 
addition of DHA. 
Procedure for obtainin blood from animals other than man 
Blood was obtained from normal rats, rabbits, and guinea pigs. 
The animals were anaesthetised with pentobarbital and dissected to 
expose the abdominal aorta. Blood was withdrawn into a heparinised 
syringe. Professor D. Whitteridge kindly supplied a sample of 
blood from a rhesus monkey. The blood was withdrawn from the 
jugular vein of an animal anaesthetised with pentobarbital. 
TABT,F 19. 
Time after 
The stability of DHA in 0.9 % (w /v) NaC1 
preparation AA Total AA DHA Loss of DHA 
(min) (mg /100m1) (mg /100ml) (mg /100ml) ( %) 
o 0 11.0 11.4 0 
30 0 11.0 11.1 2 
150 0 11.0 11.1 2 
63. 
RESULTS. 
A. The reduction mechanism in normal er throe tes. 
The stability of DHA in normal saline at pH 5.5. 
The stability of a solution of DHA in normal saline (0.9% 
w/v sodium chloride) was tested immediately, 30 min. and 150 min. 
after its preparation by comparing its indophenol reducing activity 
before and after treatment with H2S with the total AA content 
measured by the Roe & Kuether method. Aliquots of the solution 
containing approximately 10 mg. /100m1. DHA were added to 3% 
metaphosphoric acid and 6% trichloroacetic acid immediately after 
its preparation and after 30 min. and 150 min. A portion of 
the metaphosphoric acid solution was immediately treated with 
H2S at pH 3.5 and 3 7°C. The remainder was kept for the measure- 
ment of AA by the "buffered indophenol" method. A precipitate 
of sulphur, formed during treatment with H2S, was removed by 
filtration. The extracts which had been treated with H2S and 
the trichloroacetic acid extracts were diluted a thousand -fold 
for the measurement of AA. The undiluted DHA solution had no 
indophenol reducing activity even after standing 150 min. so that 
no reduction of DHA had occurred in this time at pH 5.5. The 
total AA content, as measured by the Roe method, was also unchanged. 
Immediately after preparation the reducible ascorbic acid i.e.DHA, 
was 103% of the total AA and 150 min. later it was 101%. 
These results (Table 19) show that at pH 5.5. DHA is stable 
in saline solutions and it was concluded that the quinone oxidation 
method for preparing DHA was satisfactory. In the experiments 
TABLE 20. The stability of DHA in plasma 
Time after Increase Decrease 
addition of DHA AA in AA Total AA in Total AA 
(min) (mg /100ml) ( %) (mg /100ml) ( %) 
30 0.35 2 7.32 26 
60 0.43 3 4.92 50 
120 0.45 3 1.56 84 
64. 
described in this section the DHA solutions were always used 
within 150 min. and usually within 30 min. of preparation. 
The stability of DHA in normal saline at pH g.1 
The pH of a freshly prepared saline solution of DHA was 
increased to 7.1 by the addition of phosphate buffer. The total 
AA content and the indophenol reducing activity before and after 
treatment with H2S was measured immediately and at 10, 20, 40, 
and 6o min. after the pH was raised. The total AA content remained 
unchanged and only 1% of this was detected in the solution as AA 
after 60 min., showing that no spontaneous reduction of DHA occurs 
at pH 7.1. By reduction with H28, progressive conversion of DHA 
to DKG at pH 7.1 was observed. (Fig.23). At a pH close to that 
of blood, DHA solutions are therefore unstable. In 60 min. one - 
half the DHA was converted to DKG. It was also noticed that after 
24 hr. saline solutions of DHA began to turn yellow. This was 
accelerated by making the solution more alkaline. Furthermore, 
shortly after addition of the alkali, the DHA solutions became 
strongly acid (pH 2.0) suggesting the formation of DKG. 
The stability of DHA in human_plasma. 
A saline solution of DHA was added to plasma, which had been 
equilibrated with CO, to give a final concentration of 10 mg. /100m1. 
DHA. The plasma concentration of AA and the total AA was measured 
at 30, 6o and 120 min. after the addition of DHA. A slight increase 
of 2% in the AA content was observed after 120 min. but more striking 
was the rapid fall in total AA. (Table 20). In the table the 
quantity of AA i0tially present in the plasma has been subtracted 
12r 
r-7 














Fig.23. The stability of DHA at pH 7.1. A, total AA; B, total AA 


















































































































































































































































































































































































































































TABLE 21. The fate of AA added to leucocyte -poor blood 
Plasma Cells 
Time after 
addition of AA AA Total AA AA Total AA 
(min) (mg /100m1) (mg/100ml) 
Whole blood 
A 
AA Total AA 
(mg /100ml) 
30 16.20 15.48 0.68 2.13 11.54 11.48 
60 16.40 15.36 0.76 2.31 11.70 11.45 
120 15.40 13.92 1.00 3.42 11.08 10.77 
65. 
from the readings. After 120 min. only 16% of the added DHA 
could be detected by the Roe & Kuether method. It is therefore 
concluded that in plasma although a very slight reduction of DHA 
to AA may occur most of it is oxidised further than the DKG stage. 
Since no special precautions were taken to remove the leucocytes 
completely, e.g. by filtration through a Seitz filter, the des- 
truction of DHA may have been due to leucocytes. 
The fate of AA added to normal human blood. 
To a CO- saturated sample of human blood from which the leuco- 
cytes had been removed AA was added to give a concentration of 
approximately 10 mg. /10Om1. .i3oth the AA and total AA were deter- 
mined in the plasma and erythrocytes after 30, 60 and 120 min. 
Even after 120 min. only a very small amount of the AA had diffused 
into the erythrocytes (Table 21). A small amount of the total AA 
(16 %) was destroyed during this time. 
The fate of DHA added to normal blood. 
To a CO- saturated sample of human blood from which the leuco- 
cytes had been removed as completely as possible, and with the 
p.c.v. adjusted to 30, DHA was added to give a concentration of 
approximately l0mg/1O0m1.. The AA and the "total AA was determin- 
ed in both the plasma and erythrocytes 20, 30, 6o, and 120 min. 
after the DHA had been added. The DHA :+ DKG content of these 
fractions was calculated by difference, The AA, DHA-t- DKG and 
"total AA" in the whole sample was then calculated and from these 
values the percentage of the added DHA which had been reduced, 
was determined (Table 22). The course of the reaction is shown 
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TIME (min.) 
Fig. 24. The fate of DHA added to intact erythrocytes. A, total AA; 





























































































































































































































































































































































plasma and erythrocytes made it impossible to get values earlier 
than 20 min. after the addition of DHA. The concentration of AA 
rose sharply in the first 35 min. and almost all of it was located 
in the erythrocytes. After 35 min. the 'total AA" was falling 
slowly, indicating that some destruction beyond DKG was taking 
place. Since the formation of AA after 35 min. proceeded 
slowly, the steady rise in the valuefbr the "percentage" reduct- 
ion after this time was largely due to the fall in the total AA. 
In blood therefore, the rate of reduction of DHA reached an 
optimal value between 20 and 35 min. after the addition of DHA. 
Within this time one -half of the added DHA had disappeared from 
the plasma and was found as AA in the erythrocytes. Since AA 
doss not diffuse at all readily into the erythrocytes it was con- 
firmed that reduction of DHA had taken place in the erythrocytes. 
In another experiment DHA was added to normal blood and 
after 30 and 60 min. the plasma and erythrocytes were analysed 
for AA, total AA and total AA reducible by H2S. Unfortunately 
the values obtained for the AA and DHA after H2S reduction were 
higher than the corresponding total AA values, due to the non - 
specificity of the H2S method. However the results (Table 23) 
show that even after 30 min. practically no DHA remained in 
either the plasma or erythrocytes and that the part of it which 
had not been reduced to AA had been converted to DKG. Furthermore, 
the DKG was nearly all in the plasma. It is probable that the 
conversion of DHA to DKG is brought about by the leucocytes since 
even after these had been removed as far as possible by different- 
67. 
ial centrifugation the leucocyte counts of the reconstituted 
blood were between 1500 and 2000. Thomson (1955) has shown 
that when the leucocytes are completely removed by filtration 
through a Seitz filter DHA is not converted to DKG by plasma. 
The reduction of DHA bx haemolysed erythrocytes. 
Erythrocytes from normal blood were haemolysed by adding 
7 vol. of water to 3 vol. of erythrocytes. By this means it was 
possible to follow the reduction of DHA during the first 30 min. 
after its addition. DHA, to give a final concentration of 
10mg./100m1. was added and the concentration of AA, total AA and total 
AA reducible by H2S were determined at intervals of 3, 10, 20, 
30, and 60 min. The results are shown in Fig.25. The curves 
for DHA and DKG are calculated by difference. There was no 
destruction of total AA in 60 min. and the concentration of AA 
increased steadily although the rate of formation was greater in 
the first 30 min. After 60 min. a little DHA remained. 
Approximately 16% of the DHA was converted to DKG at 60 min. and 
no more was formed even though the reaction has been followed 
for as long as 160 min. (Fig.26). 
Com2ariaon of,theCreduction of DHA by haemolysed and unhaemolysed 
erythrocytes. 
The reaction; which take place in a solution of haemolysed 
erythrocytes and in a suspension of intact erythrocytes differ 
in two respects. Firstly, in the haemolysed solutions, the 
total AA does not fall whereas in suspensions of intact erythrocytes 




Fig.25. The reduction of DHA by haemolysed eryLhrocyLes. A, total 















80 120 160 
TIME (min.) 
Fig.26. The reduction of DHA by haemolysed eryl,hrocytes. A, total 
AA; B, total AA reduced by H2S (DHA + AA); C, AA; D, DKG; 
E, DHA. 
TABT,F 25. The reduction of DHA by intact and haemolysed 
erythrocytes from different species 
Reduction of DHA 
Animal Weight Plasma AA Intact Haemolysed 
(g) (mg/100ml) ( %) ( %) 
guinea pig 340 0.73 68 58 
guinea pig 360 0.86 66 - 
guinea pig 280 0.84 64 IMO 
guinea pig 290 1.24 57 61 
guinea pig 500 0.91 6 
guinea pig 600 1.60 8 86 
guinea pig 650 1.13 13 - 
guinea pig 600 1. /1/1 7 63 
guinea pig (2) 280 0.90 52 70 
600 
rabbit - 0.99 2 28 
rabbit - 0.35 1 39 
rabbit - 0.63 1 39 
rat (4) - 0.64 3 61 
rat (3) - 1.71 0 - 
monkey adult 0.68 80 77 
TABU', 24. The reduction of DHA by intact and haemolysed 
erythrocytes 
Subject Condition 





T.B. Normal 42 42 
A.I. Normal 46 41 
J.O. Normal 46 44 
A.C. Rheumatoid 70 76 
Arthritis 
P.J. Rheumatoid 70 65 
Arthritis 
68. 
present after 30 min. in haemolysed solutions was never as great 
as that observed in the one suspension of intact erythrocytes in 
which the reducible total AA was measured. Consequently some 
AA continued to be formed after 30 min. in the haemolysed solutions 
whereas reduction was virtually complete in this time in the intact 
cells, probably because the supply of DHA was exhausted due to 
conversion of part of it to DKG. Comparing the values for the 
percentage reduction of DHA by intact and haemolysed erythrocytes 
(Table 24) it was found that after 30 min., the rate of reduction 
was the same. 
The reduction of DHA by haemolysed and intact erythrocytes of 
others ee cies 
The ability of both haemolysed and intact erythrocytes from 
guinea pigs, rats, rabbits and a monkey to reduce added DHA was 
examined, and the results are given in Table 25. Intact 
erythrocytes from rats and rabbits did not reduce added DHA. 
However when the cells were laked reduction occurred readily. 
A very small amount of reduction occurred in intact erythrocytes 
from adult guinea pigs and this was greatly in increased when the 
cells were haemolysed. In contrast, intact cells from young 
guinea pigs very readily reduced added DHA. _both intact and 
haemolysed erythrocytes from an adult monkey readily reduced DHA. 
Erythrocytes of all these species reduce DHA to varying degrees 
but there seems to be species differences in the transfer of DMA 
across the cell membrane. In rabbits and rats DHA added to 
blood does not pass easily into the erythrocytes and remains in 
the plasma. In guinea pigs DHA appears to pass much more 





after 15 min. 
(mg /100ml ) 
4.88 
AA produced 
after 40 min. 
(mg /looms) 
8.56 
Potassium cyanide 0.01 4.16 4.48 
Iodoacetic acid 0.01 2.88 3.20 






Urethane 0.35 5.00 7.76 
Sodium arsenite 0.05 2.72 2.88 
Sodium fluoride 0.05 5.00 7.04 
69. 
readily into the cells of young animals. The adult monkey 
resembles man in that DHA readily enters from the plasma into 
the erythrocytes. 
The effect of inhibitors on the reduction mechanism. 
The effect of a number of known enzyme inhibitors was tested 
in the hope that the type of reactions involved in the reduction 
of DHA might be elucidated. DHA was added to haemolysed 
erythrocytes to give a final concentration of approximately 
40 mg. /100m1. Aliquots of 9.5m1. were immediately pipetted 
into tubes containing 0.5ml. of the following inhibitors; 
potassium cyanide, iodoacetic acid, sodium azide, sodium diethyl - 
dithiocarbamate, urethane, sodium arsenite and sodium fluoride. 
The final concentrations of the inhibitors and the amount of AA 
formed in 15 and 40 min.are: given in Table 26. Only iodoacetic 
acid and sodium arsenite depressed the production of AA in 15 min. 
but after 40 min. the production of AA was reduced by one -half 
in the presence of potassium cyanide. Diethyldithiocarbamate, 
which is reported to be specific for copper -containing enzymes, 
was without effect. Sodium azide and urethane, which inhibit a 
number of dehydrogenases did not inhibit the production of AA. 
Cyanide, iodoacetic acid and arsenite inhibit -SH enzymes but 
by no means specifically. 
The effect ofdi.fferent concentrations of a specific -SH 
inhibitor, CMB, has also been examined. Aliquots of a haemolysed 
solution of erythrocytes, to which 10 mg. of DHA had been added, 
were transferred to tubes containing different concentrations of 
CMB. CUR inhibited the reduction of DHA and the inhibition 





Reduction of DHA 
(%) 
0 3.92 58 
22 3.20 48 
44 2.88 43 
66 2.72 41 
TABLE 28. The concentration of total SH groups during 
reduction of DHA 
Time after 
addition of DHA 
(min) 
AA produced Total SH 
(mg /100ml) 61g/0.1m1) 
1 0.54 16.17 
10 3.51 14.85 
15 4.22 16.50 
20 4.82 16.17 
32 6.22 16.50 
7o . 
progressively increased with the higher concentrations of CMB 
(Table 27). 
The concentrations of inhibitors are much larger than those 
usually required for enzyme inhibition. However since the DHA 
reducing system has not even been partially purified, large 
amounts of any inhibitor would probably be required to block 
the reduction completely. Mini for example will probably combine 
with all -SH groups on the cell proteins and with GSH. Never- 
theless, since some degree of inhibition was obtained with all 
the -SH inhibitors, these experiments confirm the reports in the 
literature that GSH and fixed -SH groups are involved in the 
reduction mechanism. 
The fate of -SH groups during the reduction of DHA 
If -SH groups are involved in the reduction of DHA a fall 
in their concentration might be expected during the course of 
the reduction. Total -SH groups were measured by an ampero- 
metric titration procedure in haemolysed erythrocytes at 
intervals of 1, 10, 15, and 32 min. after 10mg. /100m1. of DHA 
was added. The reduction of DHA at these times was also 
followed by estimating the amount of AA produced (Table 28). 
Although DHA reduction was normal no change in total -SH groups 
was found. Since both free and bound -SH groups are reported 
to bring about the reduction of DHA (Schultze et al., 1937, an d 
Thomson, 1955) this experiment provides strong evidence that 
some mechanism for the rapid regeneration of the oxidised -SH 
groups exists in haemolysed erythrocytes. 
The fate of reduced .pyridine nucleotides (DDN and TPN) during 
the reduction of DHA. 
_TABLE 29. Reduced pyridine nucleotides during reduction of DHA 
Time after Reduced pyridine 
Sample addition of DHA nucleotides Reduction of DHA 
Blood A 
Blood B 
















The possibility that either DPN or TPN or both these co- 
enzymes might be involved in the reduction of DHA or in the regen- 
eration of -SH groups was examined. The total reduced pyridine 
nucleotides were measured in CO - saturated blood containing 
10 mg.% (w /v) DHA. Analyses were carried out on two samples of 
blood immediately and at intervals of 5 min. after addition of 
DHA. After 30 min. the amount of DHA which had been reduced was 
determined. No change was observed in the concentration of the 
reduced co- enzymes during the first 25 min. after addition of DHA 
although approximately one -half of the DHA had been reduced to 
AA (Table 29). These experiments hówever do not exclude the 
possibility that reduced pyridine nucleotides are directly 
responsible either for the reduction of DHA or for the regener- 
ation of GSH and fixed -SH groups, since the co- enzymes may be 
rapidly oxidised from other substrates. 
The effect of substrates on the reduction of DHA. 
It has been shown in a previous experiment that there is no 
fall in the concentration of total thiol groups during the reduct- 
ion of DHA. If thiol groups are responsible for the reduction of 
DHA in erythrocytes some mechanism must be postulated for their 
regeneration. Regeneration of -SH groups could be 
coupled to the oxidation of some other substrate. 
Such an oxidation may be aerobic or anaerobic. 
Although the erythrocyte preparations were always satur- 
ated with CO, it is extremely difficult to exclude traces 
of oxygen completely. The possibility that oxidation of 
glucose, which is a normal metabolite of erythrocytes, might 
TALLE 30. The concentration of glucose during reduction of DHA 
Time after No added DHA + DHA (50mg/100m1) 
DHA addition Glucose Glucose AA produced 
(min) (mg/100m1) (mg/100m1) (mg/100m1) 
1 148 157 1.29 
5 152 152 3.96 
10 150 158 5.42 
15 - 154 6.38 
20 152 153 7.68 
30 154 161 9.28 
TABLE 31. The effect of added glucose on the reduction of DHA 
Time after No added glucose + glucose(50mg /100m1) 
DHA addition AA Total AA Reduction AA Total AA Reduction 
(min) (mg/100ml) (mg/100m1) (%) (mg/100m1) (mg/100m1) (%) 
15 3.88 10.56 37 3.92 10.56 37 
30 6.20 10.44 59 5.68 9.72 58 
72. 
be coupled with the regeneration of thiol groups was next examined. 
The concentration of glucose was followed at intervals of 
5 min. for one -half hour in :a. haemolysed solution of erythrocytes 
to which DHA, to give a concentration of 50 mg. /100m1., was added. 
Glucose was also estimated by the method of Hagedorn & Jensen 
in solutions of the same erythrocytes to which no DHA had been 
added, in order to correct for any breakddwn of glucose not con- 
cerned with the reduction of DHA. Table 30 shows that the con- 
centration of glucose remained unaltered in both the solutions, 
although large amounts of AA were formed in the solution to which 
DHA had been added. The role of glucose was further tested by 
comparing the rate of reduction of DHA in haemolysed erythrocytes 
and in haemolysed erythrocytes enriched with 50 mg. /100m1. 
glucose. To a solution of haemolysed erythrocytes DHA was added 
to give a final concentration of 10 mg. /100m1. Immediately, 
9.5ml. of the haemolysed erythrocytes were added to 0.5ml. of a 
solution containing 100 mg. glucose per 10 ml. A further 
9.5 ml. were added to 0.5 ml. water as a control. AA and total 
AA were estimated after 15 and 30 min. and the amount of DHA 
reduction was compared (Table 31). Reduction proceeded at the 
same rate in both the solutions. Since glucose does not increase 
the rate of DHA reduction and the concentration of glucose does 
not fall during the reduction of DHA it is concluded that glucose 
is not concerned in the reduction mechanism. 
The effect of other substrates on the rate of reduction of DHA. 
To aliquots of haemolysed erythrocytes, containing 10 mg. 
TABLE 32. The effect of added substrates on the reduction of DHA 
Substrate AA produced Reduction of DHA pH 
(50mg /l00ml) (mg /looms) ( %) 
None 3.00 39 7.0 
Alcohol 3.04 40 7.0 
Sodium pyruvate 3.32 43 7.0 
Sodium tartrate - 3.60 47 7.1 
Sodium succinate 3.44 44 7.2 
Sodium formate 3.56 46 7.2 
Sodium lactate 3.64 47 7.3 
73. 
of DHA /100m1. the following substrates were added to give a 
final concentration of 50 mg. /100m1. sodium lactate, sodium 
succinate, sodium tartrate, sodium pyruvate, sodium formate and 
alcohol. The results are given in Table 32. Alcohol certainly 
was without effect on the reduction mechanism. Although the 
other substrates slightly increased the amount of DHA which was 
reduced it is probable that the increase was due to the slightly 
higher pH in the erythrocyte solutions and not due to any direct 
effect of the substrates. Under the conditions of the 
experiment no substrate was found which markedly increased 
the rate of reduction of DHA either directly or through the 
regeneration of thiol groups. However, the added substrates 
may have been used by other competitive systems. 
74. 
B. The reduction of DHA bar erythrocytes from normal subjects and 
from atients with rheumatoid arthritis iron deficiency anaemia, 
tuberculosis and scurvy. 
It has been reported (Vinokurov & Silakova, 1944; Matusis, 
1951) that in some diseases tissue reduction of DHA is not normal. 
The capacity of erythrocytes to reduce DHA was therefore investigated 
in a group of individuals in normal good health, and in hospital- 
ized patients with rheumatoid arthritis, tuberculosis and scurvy. 
Erythrocytes from hospital out -patients considered to have iron 
deficiency anaemia were also examined. Tuberculosis and 
rheumatoid arthritis were selected for this study because it has 
been suggested that some disturbance of vilmin C metabolism may 
occur in these diseases. Scurvy, on the other hand is the 
classical vitamin C deficiency disease. Iron deficiency 
anaemia was examined in order to determine whether the haemo- 
globin content of the erythrocytes was related to the DHA reduc- 
ing mechanism. Furthermore, rheumatoid arthritis is usually 
accompanied by a normocytic hypochromic anaemia. The possibility 
that any change in reducing capacity might be associated with a 
chronic'illness or infection was examined by comparing the 
tubercular and rheumatoid groups with the normal group. 
The bloods which were examined were either fasting specimens 
or were obtained 2 -3 hours after a light meal. The percentage 
reduction 30 min. after the addition of DHA to intact erythro- 
cytes was determined under the standard conditions described 
on page 61. The haematocrit reading, after removal of the 


















































































































































































































































































































































































































































































































































































































































































































































































of the percentage reduction was based on the exact p.c.v. achieved. 
Data on the reducing capacity, on the total AA in plasma before 
addition of DHA and on the haematological values are summarised 
in Table 33. 
In a group of 41 "normal" subjects the mean percentage 
reduction of Added DHA was 48 (S.D. = 5.9, range 32 -59). 
Haematological data on these individuals was not available but 
the normal values given by Discombe (1954) are included for com- 
parison with those of the other groups. In blood from 31 cases 
of rheumatoid arthritis the mean percentage reduction was 62 
(S.D. = 9, range 44 -89). These patients were all receiving 
salicylate or codeine phosphate. In a few cases the reducing 
capacity was examined during salicylate therapy and later during 
codeine treatment. No difference in the percentage reduction 
of DHA was observed. In rheumatoid arthritis the range of the 
percentage reduction was wider than in the normal group and, 
as shown in Fig. 27, the distribution curves for the two groups 
overlap. The mean percentage reduction for the patients with 
rheumatoid arthritis was significantly higher than normal (p ( 0.01). 
The concentration of total AA in the plasma before the addition 
of DHA was not different from normal. The haematological data 
show the hypochromic normocytic anaemia typical of the disease. 
Comparison of the data on the reduction mechanism in the 
rheumatoid patients with that on normal subjects shows that the 
concentration of total AA in the cells was greater in the 
rheumatoid group. The concentration of AA in the cells was 
also greater. In the rheumatoid group 90% of the erythrocyte 
40 60 
REDUCTION OF DHA (%) 
Fig. 27. Frequency distribution curves for the percentage reduction 
of DHA by erythrocytes. A, normal erythrocytes (n= 41); B, 
erythrocytes from patients with rheumatoid arthritis (n= 31). 
76. 
vitamin C was present as AA whereas only 80% was in this form in 
the normal group. 
Statistical analysis of the results obtained for the blood 
from patients with iron -deficiency anaemia, tuberculosis and 
scurvy was not carried out because the number of patients avail- 
able was too small. The 3 cases of scurvy should be considered 
with the iron deficiency group since they were all anaemic. In 
this group the mean percentage reduction was 62 (range 54 to 73) 
and the individual figures for thereduction mechanism are 
comparable with those of the rheumatoid group. The concentration 
of AA in the plasma before the addition of DHA was also similar. 
In the 3 cases of scurvy this value was zero. 
The mean percentage reduction of DHA in the tuberculosis 
group was a little higher than normal. Blood was obtained from 
these patients immediately on admission to hospital and before 
any drug therapy was started. The haematological pattern for 
this group was normal. The initial levels of total AA in the 
plasma were a little lower than in. the other groups. 
The most striking feature of this investigation is the 
inverse relation between the percentage reduction and the mean 
corpuscular haemoglobin content (MCHC). Since the reduction of 
DHA is a function of the erythrocytes, the MCHC should provide 
the best haematological index for correlation with the percentage 
reduction if it is a function of the haemoglobin content of the 
erythrocytes. MCHC values below 30 are considered to be good 
evidence of an iron deficiency anaemia. In all groups where 
this index is less than 30, the percentage reduction was consider- 
77. 
ably greater than normal. It was unfortunately not possible to 
extend the investigation of the iron deficiency group and to 
measure the percentage reduction after the anaemia had been 
corrected. In another study, Thomson (1955) has shown that in 
8 patients with pernicious anaemia, the mean percentage 
reduction of DHA by erythrocytes was 67. Thomson suggested 
that the percentage reduction was inversely related to the 
haemoglobin concentration of the blood. Unfortunately, values 
for the MCHC are not included, however this index is generally 
not low in pernicious anaemia. If the percentage reduction is 
related to the haemoglobin concentration in the erythrocyte it 
is difficult to understand why the percentage reduction of DHA 
should be high in both iron deficiency and in pernicious anaemia. 
TABLE 34. Variation in the percentage reduction of DHA in the 
same individuals 
Subject Condition Date Reduction of DHA 
(%) 
A.I. Normal 4.10.54 39 
6.10.54 36 
6.7. 55 39 




J.0. Normal 10.9.54 43 
12.9.55 45 
4.10.55 41 








31.1 .55 66 
78 . 
C. The effect of dru s on the reduction of DHA by intact erythrocytes 
It has been shown that the capacity of erythrocytes to reduce 
DHA is considerably increased in some diseases. The effect on 
the reduction of DHA of several drugs which are commonly used in 
the treatment of these diseases and which produce a clinical 
improvement in the condition of the patients, was studied. The 
standard conditions of CO saturation, p.c.v., temperature and 
time under which the reduction of DHA by intact erythrocytes was 
measured have already been described. Blood was routinely 
obtained 14 hr. after the last meal. 
The normal variation in the reduction of DHA by erythrocytes 
from the same individual was first examined . 
Variation in the percentage reduction of DHA in the same individual 
During the course of a year blood was obtained from the same 
individuals for different experiments which required the measure- 
ment of the percentage reduction of DHA under standard conditions. 
In no instance did the capacity to reduce DHA alter by more than 
5% (Table 34). In the normal individuals the constancy of the 
reduction capacity is remarkable and, in fact, supplies a useful 
test of the accuracy of the experimental manipulations. Blood 
from hospital patients was not available over such long periods. 
One case of rheumatoid arthritis (W.M.) was followed for 4 months; 
the percentage reduction did not vary by more than 4% during this 
time. Since rheumatoid arthritis is a disease marked by periods 
of remission of the clinical symptoms it is possible that the 
percentage reduction of DHA. may not always exhibit this stability. 
Unfortunately no reliable, objective index of the progress of the 
79. 
disease is available. Throughout the period of investigation.: 
W.M. was considered to be an "active" case of rheumatoid arthritis. 
Although the short term effects of several drugs were tested 
during this time the values for the percentage reduction of DHA 
given in Table 34 were determined during control periods at a 
reasonable time after the administration of the drugs. 
The effect of cortisone and salie late on the reduction mechanism. 
In view of the clinical improvement in rheumatoid disease 
which follows treatment with large doses of acetyl salicylate 
( salicylate) or of adrenocortical drugs, the effect of these 
drugs on the reduction capacity of erythrocytes was examined in 
normal subjects and in patients with rheumatic disease. 
(a) The effect of salic late ingestion on the ercenta_e reduction 
of normal erythrocytes. Blood was obtained from a subject in 
normal health and the percentage reduction of DHA by the erythro- 
cytes was determined. Two days later daily dosage with 80 grains 
of salicylate began. Blood samples were obtained 3 days and 5 
days after the beginning of salicylate ingestion. Throughout the 
experiment 500 mg. of AA were taken daily. The subject had 
reached saturation with AA before the first blood sample was 
withdrawn. Since the concentration of AA in the blood does not 
affect the reduction mechanism (as found in the large series of 
normal individuals) and the high initial levels of AA are allowed 
for in the calculation of the percentage reduction, the daily 
ingestion of 500 mg. of AA probably does not influence the effect 
of the salicylate. The results are presented graphically in 
















Fig.28. The effect of cortisone and salicylate on the percentage 
reduction of DHA by erythrocytes. A, salicylate on normal cells; B, 
cortisone on normal cells; C, salicylate on cells from a case of 
rheumatic fever. 
TABT1 35. The effect of cortisone on the reduction of DHA 
by normal er,yLhrocytes 
















3 50 150 - ONO 
4 50 150 - - 
5 50 150 20 69 
6 50 150 NINO 
7 50 150 - - 
8 50 loo - - 
9 50 75 20 48 
10 50 50 - - 
11 50 25 - - 
12 50 - - - 
13 50 - - - 
14 50 - - - 
15 50 - - - 
16 50 - - - 
17 50 - - - 
18 50 - 20 60 
1 month later - 20 53 
Diet:- Low in vitamin C; no fruit, green vegetables or turnip. 
Vitamin C supplement and cortisone given after breakfast. 
Blood withdrawn before breakfast. 
80. 
in the percentage reduction was observed. The effect of these 
high doses of salicylate could not be followed over longer periods 
because of the unpleasant subjective symptoms associated with 
its continued ingestion. 
(b) The effect of cortisone ingestion on the reducing capacity 
of normal erythrocytes. Blood was obtained from a subject in 
normal health 2 days and 6 days after the beginning of daily 
ingestion of 150 mg. of corticone acetate. Unfortunately a 
blood sample was not taken before cortisone treatment began. 
Blood was obtained 6 days and 40 days after the last dose of 
cortisone. It is considered that the percentage reduction of 
this latter sample represents the normal value for this individ- 
ual. Details of the experiment are given in Table 35 and the 
results are plotted graphically in Fig.28b. After 2 days the 
percentage reduction of 68 was 10% above the upper limit of the 
normal range. It fell to 48% and then rose again and 6 days and 
40 days after the last dose of cortisone it was within the normal 
range. These results show that cortisone had a marked effect on 
the metabolism of the erythrocytes but it is not possible to 
explain the result. 
(c) The effect of salicylate on the reducing capacity of erythro 
motes from a atient with acute rheumatic fever. Blood was 
obtained from a patient with acute rheumatic fever with no 
previous history of salicylate treatment. Treatment with sali- 
cylates (80gr. per day) was begun and blood samples were obtained 
on the third and the tenth day after the beginning of treatment. 
As shown in Fig.28c, salicylates had no effect on the DHA reducing 
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capacity of the erythrocytes. 
(d) The effect of AA on the reducing capacity of rheumatoid 
erythrocytes. In one patient with rheumatoid arthritis the DHA. 
reducing capacity was followed during treatment with 500 mg. of 
AA daily for 8 days. Two fasting blood samples were obtained 
before treatment and further samples were taken 1, 3, and 6 days 
after treatment began. Five days after the administration of 
AA had been stopped another sample was taken. The results are 
given in Fig.29. There was a large rise in the plasma AA 
following AA administration and a sharp fall on its withdrawal. 
The small fluctuations in the DHA reducing power of the erythro- 
cytes are considered to be no more than the normal variations in 
a patient of this type, so that the reducing capacity appears to 
be unaffected by the plasma AA level. 
It is never possible to withhold analgesics completely from 
patients with rheumatoid arthritis, so that in all experiments 
where salicylate was withheld it was replaced by codeine phosphate. 
It is unlikely that codeine phosphate has any marked effect since 
2 months later when the patient was again on salicylate treat- 
ment the percentage reduction of DHA was unchanged. 
(e) The effect of cortisone on the reducing capacity of rheumat- 
oid erythrocytes. The reducing capacity of erythrocytes 
from a patient with rheumatoid arthritis was followed during a 
short period of cortisone therapy. This experiment was of 
particular value because it was possible to repeat it on the 
same individual; first with cortisone supplemented with a high 













Fig.29. The effect of daily ingestion of 500mg. of AA on the 
percentage reduction of DHA by rheumatoid erythrocytes. Patient, 
J.J1., female, rheumatoid arthritis. A, total AA in plasma (mg. /100m1) 
B, percentage reduction. 
TABLE 36. Protocol for the experiments on the effect of cortisone 












































6 50 - 20 500 - - 
7 50 - - 50o - 20 
8 50 - 20 500 - - 
9 5o 150 - 500 150 - 
10 50 150 20 500 150 20 
11 50 150 - 500 150 - 
12 50 150 20 500 150 - 
13 50 150 - 500 150 20 
14 50 100 - 500 100 - 
15 50 75 20 500 75 20 
16 50 50 - 500 50 - 
17 50 25 20 500 25 20 
18-21 50 - - 500 - - 
22 50 - 20 500 - 20 
Diet:- Low in vitamin C; no fruit, green vegetables or turnip. 
Vitamin C supplement and cortisone given after breakfast. 
Blood withdrawn before breakfast. 
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cortisone therapy was begun 2 samples of blood were taken. 
Samples were also taken on the first, third, sixth and eighth 
day after it was started. A final specimen was collected 5 
days after the last dose of cortisone. The experimental details 
and results are given in Table 36 and Fig.30 respectively. 
Cortisone administration produced wide fluctuations in the 
values for the percentage reduction of DHA. After 2 days the 
value had fallen to 35% and 3 days later it was 85 %. Cortisone 
treatment was then gradually stopped and the value for the 
percentage reduction fell to the original value. 
These changes were so dramatic that the experiment was 
repeated one month later with the difference that a supplement 
of 500 mg. of AA per day was given. The experimental details 
are given in Table 36 and the results in Fig.30. The control 
level, 7 days after AA administration was started but before 
cortisone was given, was exactly the same as in the previous 
experiment. This result confirms the conclusion that the level 
of AA intake does not affect the reducing capacity of erythro- 
cytes. The response to cortisone is strikingly similar in the 
2 experiments. A sudden fall at the third day is followed in 
both experiments by a rapid rise to a very high level, with a 
return to the original level after the cortisone is stopped. 
The duplication of the cycle together with the size of the 
responses suggests that in this patient cortisone elicited a 
definite response of the reducing mechanism in the erythrocyte. 
Since the response was the same on both a low and a high level 









Fig. 30. The effect of cortisone on the percentage reduction of 
DHA by rheumatoid erythrocytes. Patient, W.M. male, rheumatoid 
arthritis. o - o low AA diet (50 mg. AA /day); - high AA. 
diet (500mg. AA /day). 
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cortisone. Although no explanation of the changes is offered 
it is likely that changes in the activity of the adrenal cortex in 
response to cortisone administration in some way cause the changes 
in erythrocyte metabolism. Any direct effect on the erythro- 
cyte might be expected in less than 3 days and would probably 
lack the strongly marked rhythmic character of the response. 
(f) The effect of ACTH on the reducing capacity of rheumatoid 
erythrocytes. The response of the reducing mechanism to ACTH 
treatment was followed in the same patient (W.M.) at daily 
intervals for 12 days. Daily injections of 40 mg. ACTH were 
given after the specimens of fasting blood had been withdrawn. 
The results are plotted in Fig.31. The initial value for the 
percentage reduction was the same aß in the 2 prior experiments. 
Within 24 hr. of the first ACTH injection the value had fallen 
to the very low level of 30%. In the next 24 hr. it rose 
sharply to 74% then fell to 60%. After this it rose progress- 
ively to 75% when the ACTH administration was discontinued. 
The cycle of changes following ACTH administration was similar 
to that elicited by cortisone treatment with the difference 
that the changes occurred sooner with ACTH therapy. The 
clinical effects of ACTH treatment are also earlier in onset 
than those due to cortisone therapy. The fact that ACTH has 
a similar effect to cortisone supports the hypothesis that the 
action is an indirect one operating through changes in supra- 
renal activity. 
(g) The effect of 'neticorten on the r educin. activit of 






Fig. 31. The effect of ACTH on the percentage reduction by rheumatoid 
erythrocytes. Patient, W.IVi., male, rheumatoid arthritis. Dosage: 
40 mg. ACTH per day. 
TABLE 37. The effect of Meticorten on the reduction of DHA by 
rheumatoid erythrocytes 
Time Meticorten Reduction of DHA 
(hr) ( %) 
0 - 64 
12 50 mg 
24 - 73 
48 - 64 
TABLE 38. Pr oto.col of the experiments on the effect of salicylate on 
the reduction of DHA by rheumatoid erythrocytes. Patients, 
P.J., B.W. and M.T. 
Days AA supplement Salicylate Na of blood samples taken 
(mg /day) (gr /day) 
1 - 14 None - 2 
15 - 28 500 - 2 
29 - 42 500 80 2 
43 - 49 500 - 1 
50 - 57 None - 2 
TABT,F 39. Protocol of the experiments on the effect of cortisone 
on the reduction of DHA by rheumatoid eryLhrocytes. 
Patients, A.McL. and A.C. 




of blóod samples taken 
A.McL. A . C . 
1 - 14 - - 2 2 
15 - 28 500 - 2 2 
29 - 38 500 150 4 4 
39 500 100 - 
40 500 75 1 - 
41 500 50 - 1 
42 500 25 - - 
43 500 - 1 1 
44 - 49 500 - 1 1 
50-57 - - 1 1 
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percentage reduction of DHA of a single dose of meticorten was 
examined in a patient with rheumatoid arthritis. Meticorten 
is a synthetic adrenocortical drug reported to have very little 
effect on electrolyte metabolism and to have a more powerful 
effect on steroid metabolism than cortisone. 
A specimen of blood from the fasted patient was obtained 
and the percentage reduction of DHA was determined. Twelve hr. 
later a dose of 50 mg. of meticorten was given. Further 
blood samples were taken 12 and 36 hr. after the meticorten was 
given. Twelve hr. after dosage, the percentage'red.uction 
increased from 64 to 73% and 24 hr. later it had fallen to the 
original level (Table 37). 
It is concluded that the effect of adrenocortical drugs 
on erythrocyte reducing capacity is probably not associated with 
their effects on electrolyte metabolism. 
(h) 22mparison of the effects of salicylate and cortisone during 
a long eriod of administration of large doses of AA to patients 
with rheumatoid arthritis. Protocols of the experiments are 
given in Tables 38 and 39. The effect of salicylate was 
examined in 3 patients and the effect of cortisone in 2 patients. 
Specimens of fasting blood on which the percentage reduction 
of added DHA was determined were taken during each of the follow- 
ing 5 periods of the experiment. 
(a) a preliminary control period of 15 days during which 
none of the drugs were given; 
(b) a period of 14 days when 500 mg. of AA was given daily; 
(c) a period of 14 days during which either cortisone or 
TABLE 40. Details of treatment, plasma AA, haematological values 

















100mg Nicotinic Acid 
50mg AA /day 
J, 









0 42 20 27 71 
1.18 50 29 29 74 
68 33 30 
1.18 85 38 33 44 
0.88 90 41 33 63 
0.67 90 41 33 57 
0.45 - 41 - 58 
0.52 - 41 - 57 
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salicylate was given in addition to the AA. On the last 4 
days of this period the cortisone dose was gradually reduced; 
(d) a period of 7 days when only AA was given; 
(e) a final period during which none of the drugs were given. 
In the salicylate experiments (Fig.32 a,b,c,) the percent- 
age reduction of DHA varied considerably. Although these 
changes were as much as 10% they were not causally related to 
the administration or withdrawal of either salicylate or AA. 
A composite graph in which the mean values for the 3 experi- 
ments are plotted is shown in Fig. 32d. It is evident from 
this graph that the fluctuations in percentage reduction were 
random. 
In the 2 cortisone experiments (Fig.33a and b) the values 
for the percentage reduction of DHA rose steadily throughout 
the period of cortisone treatment. Furthermore, the high 
level was sustained for at least one week after cortisone was 
withdrawn and then fell slowly to the original level. The 
composite graph of the results (Fig.33c) shows clearly that 
the increase in the percentage reduction was related to the 
administration of cortisone and not to the AA. 
Changes in the erythrocyte reducin capacity of a patient with 
frank scurvy. 
The details of the treatment with AA, nicotinic acid, 
and a vitamin "B complex" preparation, together with the 
values for plasma AA, haemoglobin, p.c.v., MOHO and percentage 
reduction of DHA are given in Table 40 and Fig.34. Unfortun- 
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Fig.32. The effect of salicylate on the percentage reduction c DHA 
by erythrocytes from patients with rheumatoid arthritis. A, P.J., 
male; B, B.W., female; C, PMT., female; D, composite graph of A,B 
and C. Dosage:- salicylate, 80gr. /day; AA, 500mg. /day. 
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Fig. 33. The effect of cortisone on the percentage reduction of DHA 
by erythrocytes from patients with rheumatoid arthritis. A, A.C., 
male; B, A.McL., male; C, composite graph of A and B. Dosage: - 
cortisone, 150 mg. /day, reduced gradually during the last 4 days; 

















































































































































































































































the case of the intravenous injection of nicotinic acid, and a 
value for the percentage reduction could not be determined 
immediately before this. No record of any treatment with 
iron is recorded so it is assumed that the correction of the 
marked iron deficiency anaemia was due to the improved diet 
and the AA supplements, since this occurred before vitamin B 
was given. Initially the percentage reduction was very high 
and is similar to that found in cases of iron deficiency anaemia. 
On the twenty -third day the percentage reduction had fallen to 
44. It was then discovered that alar;e dose of nicotinic acid 
had been injected 4 days prior to this. It cannot be asserted 
with certainty that this very marked fall in the reducing 
capacity was due to the nicotinic acid and not due to the improve- 
ment in the anaemia. However 4 days before the injection the 
MCHC of 30 was still below the normal value for males (i.e.33) 
and the anaemia was therefore not fully corrected. Furthermore, 
when the DHA reducing capacity of the erythrocytes was determined 
again, it had increased during the next 4 days to 63. By this 
time the MCHC was 33. It is probable therefore that the 
nicotinic acid did contribute to a temporary lowering of the 
reducing capacity. During the next 8 weeks the patient was 
treated with a proprietary preparation of vitamin B. After 
8 days the value for the percentage reduction had fallen 
further to 57 and remained at this level. No details of the 
amounts of the individual vitamins of the vitamin "B complex" 
preparation were available; however it would undoubtedly con- 
tain some nicotinic acid. The fall in the percentage reduct- 
TABLE 41. The effect of nicotinic acid (100mg. i.v.) on the 
reduction of DHA by erythrocytes 
Reduction of Reduction of DHA Reduction of DHA 
DHA before 2 days after 4 days after 
Subject Plasma AA nicotinic acid nicotinic acid nicotinic acid 
(mg /100ml) ( %) (%) (%) 
N. 
(rheumatoid) 
0.22 64 61 54 
0. 
(rheumatoid) 0.12 60 54 55 
C. 
(rheumatoid) 0.26 71,67 54 58 
F. 
(rheumatoid) 0.10 67,63 52 
S. 
(scurvy) 1.18 63 - 73 44 
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ion from 63 to 57, which is in the upper range of normality, 
could be attributed either to vitamin B or to the correction 
of the anaemia. 
The effect of nicotinic acid on the erythrocyte reducing capacity. 
The results of the previous experiment suggested that 
nicotinic acid might have an effect on the erythrocyte reducing 
mechanism. Since this was the only experiment in which a fall 
to the normal value for the percentage reduction had been 
observed it was considered of interest to examine the effect of 
nicotinic acid more closely. The percentage reduction of DHA 
was therefore determined in patients with rheumatoid arthritis 
before and after the injection of 100 mg. of nicotinic acid. 
Rheumatoid patients were selected because it has been shown that 
the value for the percentage reduction is high in this disease. 
The results are summarised in Table 41. In every case a fall 
in thexeducing capacity was observed between 2 and 4 days after 
the injection. It is therefore probable that in the previous 
experiment, nicotinic acid was responsible for the low value 
observed 4 days after its administration. Whether injection 
of nicotinic acid would bring about a fall in the erythrocyte 
reducing capacity of normal erythrocytes is not known. No 
figures are available for the blood nicotinic acid levels of 
normal subjects and patients with rheumatoid arthritis. 
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DISCUSSION 
Three aspects of the ability of human erythrocytes to 
reduce DHA have been investigated; (a) the mechanism of the 
reduction, (b) changes in the reducing capacity during various 
diseases and (c) the effect of the administration of certain 
drugs on the reducing capacity. 
The mechanism of the reduction of DHA. Preliminary experiments 
confirmed the reports in the literature that solutions of DHA 
at pH 7.0 are rapidly converted to DKG. At a lower pH e.g. 5.5, 
DHA is relatively stable for a period of at least 2.5 hr. 
At neither pH does any reduction to AA occur. Ascorbic acid 
is also known to be unstable in pure solution. In plasma, added 
DHA is very rapidly changed to substances which no longer form 
phenylhydrazine derivatives. This oxidation however is probably 
to be ascribed to the presence of a few leucocytes. 
When added to human blood from which the leucocytes have been 
removed as completely as possible, DHA rapidly passes into the 
erythrocytes and is converted to AA. Erythrocytes, however 
are relatively impermeable to AA and therefore AA formed in the 
cells diffuse:,back into the plasma only slowly. These phenomena 
have been previously reported by Schultz et al. (1937), 
Heinemann (1941) and Lloyd (1951). 
Examination of the course of the reduction in intact 
erythrocytes over 2 hr. shows that rapid formation of AA occurs 
in the erythrocytes during the first 30 min. after adding 
10 mg. % (w /v) DHA. After this time very little more AA is 
formed. The concentration of total AA in the blood remains 
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constant for 30 min. but a slow decay to substances which do not 
form ozazones with phenylhydrazine sets in after this time. 
Furthermore, after 30 min. practically none of the total AA 
remaining in the plasma can be reduced by H2S. Dehydroascorbic 
acid can therefore be metabolised by two processes. It can 
diffuse into the erythrocytes and there be reduced to AA or it 
can be converted to DKG in the plasma. This latter process 
no doubt limits the amount of DHA reduced by the erythrocytes 
to AA, since no further DHA would be available in the plasma 
after 30 min. These reactións proceed simultaneously and, 
under the standard conditions used, DHA is converted at equal 
rates to AA and DKG in normal blood. The formation of DKG from 
DHA may not be a function of the plasma itself but rather of 
the since was never possible of them 
by the differential centrifugation method used. 
The mechanism for the reduction of DHA can be isolated almost 
completely from the mechanism which converts DHA to DKG by using 
erythrocytes haemolysed with water. Under these conditions 
the same amount of AA is formed during the first 30 min. as is 
formed by the intact erythrocytes suspended in plasma. However 
reduction continues for a further 60 min. in the haemolysed 
solutions and at the end of this time between 70 and 9D% of the 
added DHA is reduced. A small amount of DHA remains in the 
haemolysed solution even after 160 min. Some DKG is also 
formed but both reactions reached completion in 90 min. It 
is possible that an equilibrium was attained between the remain- 
ing DHA and DKG since a zero level of DHA was never observed. 
90 
On the other hand the methods for differentiating between DKG 
and DHA in the blood depends on the reduction of the latter 
compound with H2S, and this procedure has never been found to 
be entirely satisfactory. Penney & Zilva (1943b) have shown 
that some indophenol reducing material is produced by H2S treat- 
ment of DKG. The slow conversion of DHA to DKG may have been 
due to the presence of a few leucocytes in the erythrocyte 
suspension but on the other. hand it has never been demonstrated 
that a small conversion of DHA to DKG does not occur in erythro- 
cytes. 
Considering the structures of the compounds concerned the 
following reactions can be enumerated:- 
g q (i ö 
0 
é Ç - OH C - OH 
I 
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HO -D -2H O = C H2O 0 = Ç +2H HO -Ç 
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Both the reversible reduction of DHA to AA and the conversion of 
DHA to DKG are reactions which have been firmly established. 
A hypothetical intermediate, monodehydroascorbic acid, in the 
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reaction AA DHA has been postulated by Berssonoff & 
Woloszyn, (1936). Lloyd & Sinclair (1953) have suggested that 
a compound of this type might be the form of the vitamin which 
is active in metabolic reactions. 
The possibility of the formation of a substance related to 
DKG in the same way that AA is related to DHA has never been 
fully explored. Rheichstein & Gussner (1934) consider that 
this substance, which is the tautomeric form of 2- ketogulonic 
acid, is capable of conversion to DHA. Such a substance 
presumably could reduce indophenol and might therefore be respons- 
ible for the increase in indophenol reducing activity which 
Penney & Zilva (1943b) found after treating DKG with H2S. 
These workers did not consider that the increased reducing activity 
was due to the conversion of DKG to AA. Such a reaction however 
is probably not important biologically, at least in the mechanism 
in the intact erythrocyte suspension since no material, reducible 
by H2S, was found 60 min. after the addition of DHA. No certain 
explanation can be offered for the presence of the material, 
which can be reduced by H2S, after the reduction of DHA to AA 
had reached completion in the haemolysed solutions. It can only 
be suggested that an equilibrium between DKG and DHA or between 
DKG and the tautomeric compound such as that suggested above was 
established. 
Several workers have reported that the reduction of DHA in 
erythrocytes occurs directly by the oxidation of GSH and fixed 
-SH groups (Schultz et al., 1937; Thomson, 1955). However the 
concentration of total -SH groups does not fall during the 
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course of DHA reduction. The reduction of DHA must therefore 
be governed by a mechanism which regenerates GSSG since it has been 
reported that erythrocytes can reduce enormous quantities of DHA 
when it is added in successive amounts (Lloyd & Parry, 1954; 
Thomson, 1955). 
Thomson (1955) has observed that the reducing mechanism in 
erythrocytes exhibits some features of an enzyme system. Since 
GSH can directly reduce DHA it is suggested that these character- 
istics are related to an enzyme system concerned with the regener- 
ation of thiol groups. In the course of the present work 
several experiments were carried out in an attgmpt to establish 
some of the properties of such a system. The levels of reduced 
pyridine nucleotides were followed during the reduction of DHA. 
Although no fall was observed, the participation of the coenzymes 
is not eliminated since reduced coenzymes are rapidly regener- 
ated. TPN is concerned in the reduction of GSSG by glutathione 
reductase in rat liver (Ball & Lehninger, 1952). The presence 
of glutathione reductase in blood has not yet been reported. 
Indirect evidence that DPN takes part in the reduction in plant 
tissue has also been put forward (James & Cragg, 1943, 1944). 
Inhibitors such as CLB, iodoacetate and arsenite which are known 
to inhibit -SH enzymes partially inhibited the reduction of DHA 
added to blood. The concentrations of these substances were much 
in excess of the concentrations usually required to inhibit an 
enzyme system. Since the proteinOcontent of the erythrocyte 
solutions is high it is not surprising that large amounts of 
the inhibitors were required to produce an effect on the reduction. 
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However, the fact that a partial inhibition was observed indi- 
cates that thiol groups are concerned in the reduction mechanisii. 
Cyanide also inhibited the/eduction but this is a relatively 
non -specific inhibitor. Azide, fluoride, diethyldithiocarbamate 
and urethane had no effect on the reduction of DHA. 
The reduction of GSSG or of oxidised pyridine nucleotides 
must eventually involve the coupled oxidation of some substrate. 
Eddy (1952) has reported that reduction of DHA by bacteria is 
stimulated by the addition of alcohol, malate, succinate, glucose, 
glycine, formate and lactate. However the rate of DHA reduction 
in haemolysed erythrocytes is not increased by the addition of 
glucose, alcohol, formate, tartrate, lactate, succinate or 
pyruvate. 
Erythrocytes from a number of species reduce DHA. The 
failure of Pant4eva (1950) to observe reduction in erythrocytes 
from horse, cat, pig, dog and rabbit is undoubtedly due to the 
fact that he used intact erythrocytes. Rapid reduction in 
haemolysed solutions of erythrocytes from rabbits and rats 
was found in the present study. Since the erythrocyte membrane 
of these animals is impermeable to DHA, reduction does not occur 
when it is added to suspensions of intact cells. Of the 
species examined only the erythrocytes of man, monkey and young 
guinea pigs are readily permeable to DHA. This observation is 
of interest since it is only these species which are unable to 
synthesise adequate supplies of vitamin C for normal body 
requirements. The significance of the permeability of the 
erythrocyte to Dia in the general metabolism of vitamin C and 
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in the production of scurvy is quite unknown. 
The evidence collected in this report on the metabolism of 
vitamin C in normal human blood confirms the reports in the 
literature. Dehydroascorbic acid when added to blood is 
rapidly destroyed by reduction to AA in the erythrocytes and 
by conversion to DKG in the plasma or the leucocytes. It is 
therefore not surprising that the presence of DHA could not be 
demonstrated in the large series of plasmas which were investi- 
gated and reported in Section I. 
In addition to the direct action of -SH groups in bringing 
about the reduction of DHA a supplementary mechanism must be 
postulated for the regeneration of these groups. Further 
information on the reactions involved in this mechanism will 
be more readily obtained when isolation of the system from the 
many other metabolic processes in erythrocytes has been achieved. 
The change in the reducing capacity of erythrocytes during some 
diseases. 
The mean percentage reduction of DHA in intact erythrocytes 
from patients suffering from rheumatoid arthritis is signifi- 
cantly higher than that in erythrocytes from individuals in 
normal good health. That this difference is a function of the 
erythrocytes and not of the supporting plasma is established by 
the fact that the difference in reducing capacity is still 
maintained when the erythrocytes are haemolysed with water. 
It is also clear from this experiment that the high reducing 
power of intact rheumatoid cells cannot be due to an increased 
permeability of the erythrocyte membrane. The most character- 
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istic difference between normal erythrocytes and those of 
rheumatoid patients is the low haemoglobin content of the latter. 
No correlation between the MCHC and the percentage reduction 
could be found within the rheumatoid group. To test the hypo- 
thesis that there may be an inverse relation between normal 
and hypochromic cells the percentage reduction was examined in 
patients with iron deficiency anaemia. In this group of patients 
the percentage reduction was also high. The possibility that 
the difference in reducing capacity might be due to a chronic 
illness or infection was examined by measuring the reducing 
capacity of erythrocytes from patients with untreated tuber- 
culosis. The mean percentage reduction in this group was alittle 
higher than normal but in only one case was the percentage 
reduction clearly beyond the normal range. The mean value for 
the MCHC was also normal. From these results it appears that 
erythrocytes with a low haemoglobin content reduce DHA more 
rapidly than do normal cells. However, in a small group of 
patients with pernicious anaemia Thomson (1955) found a high 
erythrocyte reducing capacity. 
No explanation can be offered for the finding that erythro- 
cytes with a low haemoglobin content reduce DHA more rapidly 
than normal erythrocytes. 
The effect of the administration of drugs on the erythrocyte 
reducing capacity. 
It has been claimed from studies based on the examination 
of the concentration of AA in the plasma and on the response to 
saturation doses of AA that the metabolism of vitamin C in 
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rheumatoid arthritis is not normal. However most of these 
studies have been carried out in North America where the normal 
plasma levels are much higher than in Great Britain. In the 
present study it was found that there was no difference in the 
plasma levels of total ascorbic acid in a group of normal 
individuals and in groups of patients suffering from rheumatoid 
arthritis, tuberculosis and iron deficiency anaemia. 
The administration of AA has been reported to have bene- 
ficial effects on patients with rheumatoid arthritis (Massell 
et al., 1950). In the present study daily administration of 
500 mg. of AA did not alter the capacity of erythrocytes to 
reduce DHA. This abnormality in vite.min C metabolism in rheu- 
matoid arthritis is not corrected by AA therapy and may therefore 
simply reflect a generalised increased catabolism of the vitamin. 
The effect of large doses of acetyl salicylate on the erythro- 
cyte reduction of DHA was also examined, since salicylate admin- 
istration is the standard therapy for rheumatoid arthritis. 
Salicylate administration did not increase the percentage reduct- 
ion in normal erythrocytes nor did it alter the rate of reduction 
in rheumatoid cells. Cortisone on the other hand produced a 
temporary increase in the rate of reduction in normal erythrocytes 
and it increased the already high reduction in rheumatoid cells. 
The suggestion that cortisone causes tissues to become ilmore 
reducing" has already been made by Loxton & Le Vay (1953) 
This has been confirmed for erythrocytes in the present investi- 
gation. The mechanism by which the effect is brought about is 
unknown but from the results of a short experiment it is thought 
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that the wide fluctuations in the percentage reduction may reflect 
changes in the activity in the adrenal cortex in response to 
cortisone. These fluctuations could be repeated in the same 
individual. It is possible that following cortisone admini- 
stration cyclic changes occur in the adrenal gland in which 
periods of great activity alternate with ones of low activity 
until a stable level is reached. Certainly in the long term 
experiments the rate of DHA reduction in the erythrocytes gradually 
reached a high stable level after 6 days. Similar fluctuations 
in the DHA reducing activity of erythrocytes were found after 
the administration of ACTH, which would support the hypothesis 
that the effect is an indirect one related to the adrenal gland. 
A single dose of meticorten, which is reported to have little 
effect on electrolyte metabolism but a very powerful effect on 
steroid metabolism, also produced a sharp rise in the erythrocyte 
reducing capacity. 
The only drug which was found to have any effect on lowering 
thereducing capacity of erythrocytes was nicotinic acid. 
Following an intravenous injection of nicotinic acid a temporary 
lowering of the reduction rate was observed in erythrocytes from 
4 patients with rheumatoid arthritis and one patient with acute 
scurvy. No explanation can be offered for this effect. 
Only tentative conclusions can be drawn from the results 
on the effects of certain drugs on the reducing mechanism. 
It is suggested that in some way the adrenal cortex can control 
the oxidation reduction potential of cells and that drugs which 
may modify the activity of the gland have an indirect effect on 
98. 
the reducing capacity of erythrocytes. Not only the rate of the 
reduction of DHA is affected but also probably the rates of many 
other reducing systems in the erythrocytes. Loxton & Le Vay 
(1953) interpret their results on the effects of cortisone on 
tissue potentials as a general increase in the reducing capacity 
of cells. It is difficult to imagine how such an effect could 
be due to the direct action of cortisone on cells and not be an 
effect mediated through some hormonal mechanism. 
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SMEARY 
1. A critical examination of the chemical methods for the esti- 
mation of vitamin C in biological materials has been carried out. 
The limitations of the methods are discussed. 
2. The reaction of various sulphur compounds with indophenol 
and the interference which their presence would cause in the 
estimation of ascorbic acid by indophenol, has been examined. 
3. A method has been developed for increasing the specificity 
of the indophenol method for the determination of ascorbic acid 
in mammalian extracts by the use of CAB. 
4. It is concluded from the comparison of results obtained by 
different methods that the DHA content of human plasma is less 
than is generally believed and it constitutes an insignificant 
part of the total AA. 
5. DHA added to human blood undergoes two metabolic processes. 
It is reduced to ascorbic acid by the erythrocytes and it is 
converted to DKG and to substances which do not form ozazones 
with dinitrophenylhydrazine, probably by the leucocytes. The 
mechanism for the reduction of DHA has been investigated. 
Although thiol groups are involved directly or indirectly in 
the reduction mechanism, they are rapidly regenerated, probably 
by an enzyme system. The enzyme system may involve phospho- 
pyridine nucleotides but the ultimate hydrogen donor is unknown. 
loo. 
6. A significant difference from the normal capacity of erythro- 
cytes to reduce added DHA was found in certain diseases. The 
mean percentage reduction of DHA by normal erythrocytes was 48 
(n = 41 S.D. = 5.9, range m 32 to 59). In rheumatoid arthritis 
the mean percentage reduction was 62 (n a 31 S.D. = 9, range = 44 
to 89) The mean percentage reduction of erythrocytes from 
patients with tuberculosis and iron -deficiency anaemia was 54 (n s 8) 
and 62 (n = 10) respectively. Three patients with acute scurvy 
had a high erythrocyte reducing rate. There was a tendency for 
the rate of reduction of DHA to be inversely related to the 
haemoglobin content of the erythrocyte. 
7. Salicylate administration had no effect on the reducing 
mechanism. Adrenocortical drugs such as cortisone, meticorten 
and ACTH increased the rate of reduction of DHA by rheumatoid 
erythrocytes. Injection of nicotinic acid caused a temporary 
fall in the reduction rate of erythrocytes from patients with 
rheumatoid arthritis and scurvy. 
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